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ABSTRACT 
EVALUATION OF AN ENHANCED MAGNETO-CHEMICAL PROCESS FOR THE 
REMOVAL OF PATHOGENS IN WASTEWATER 
by 
Christine N. Wright 
University of New Hampshire, May, 2008 
New wastewater treatment technologies are a necessity as a result 
of increasingly stringent discharge standards, particularly concerning 
viruses. The traditional approach to wastewater treatment consists of 
biological treatment, such as trickling filters, biofilms, and activated 
sludge. Although these biological processes have been an adequate 
means of wastewater treatment, they are intrinsically limited by their 
biological nature. A magneto-chemical process, known as CoMag™, has 
been developed to improve coagulation and solids separation and expand 
upon conventional wastewater treatment techniques. 
The research objective of this project was to develop and evaluate 
a bench-scale model of the CoMag™ process for the removal of MS2, 
poliovirus type 1, rotavirus strain Wa, and adenovirus type 2 from 
secondary effluent wastewater, at 24°C and 4°C. Additionally, the 
removal of MS2 was assessed using a 100 gpm CoMag™ pilot plant. The 
xiv 
results indicate that there was a statistically significant difference (when 
a=0.050) in the removal of MS2, when magnetite is added, versus when 
magnetite is not added. In addition, results suggest that MS2 was 
removed more effectively using the bench-scale model then the 100 gpm 
pilot plant. Employing the bench scale model, the mean Log Reduction 
Value for MS2, poliovirus type 1, rotavirus strain Wa and adenovirus type 2 
was 2.9182, 3.3893, 3.5313, and 3.482 respectively. Moreover, there was 
no statistically significant difference in the removal of MS2, rotavirus strain 
Wa, and adenovirus type 2 at 24° and 4°C. There was, however, a 
statistically significant difference in the removal or poliovirus type 1 at 24° 
and 4°C. 
This research demonstrates that the CoMag™ process has the 
ability to achieve > 2 log removal of MS2 and >3 log removal of poliovirus 
type 1, rotavirus strain Wa and adenovirus type 2. Therefore, the 
CoMag™ process' has the potential to aid wastewater and water 
treatment facilities meet their more stringent water quality permits. 
XV 
INTRODUCTION 
Enteric viruses that can be transmitted from environmental sources 
to humans are present in excess of 150 serotypes (Fong and Lipp, 2005). 
Viruses are negatively charged particles and are readily adsorb to 
particle surfaces. The adsorption of viruses to a surface is affected by the 
viral capsid proteins and more importantly the viral surface charge. 
Factors which influence viral adsorption are pH, ionic strength, electrolytes 
and interfering substances present in the water such as organics and 
heavy metals (Bitton et al., 1976). 
Wastewater disinfection strategies are designed on the basis of 
bacterial removal and do not necessarily protect the public against viral 
infection. Viruses are not generally removed as successfully as bacteria by 
conventional disinfection processes. In water, the reduction of viral 
particles fundamentally depends on two processes: inactivation and 
adhesion-aggregation (Gassilloud and Gantzer, 2005). The use of 
disinfectants to inactivate microorganisms in public water supplies is 
credited as one of the greatest public health advancements of the 20th 
century. 
Chlorination is the most widely used method of disinfection in the 
l 
United States and has been vital in minimizing the occurrence of microbial 
waterbome disease. However, chlorine can combine with contaminants 
naturally present in source waters, such as organic matter, to produce 
harmful disinfection by-products (DBPs). DBPs are toxic to aquatic life, 
even in small quantities, and are linked with a variety of adverse human 
health effects ranging from reproductive disorders to cancer 
(Nieuwenhuijsen et al., 2000). Furthermore, chlorine disinfection, using 
practical doses and contact time, does not eliminate waterbome 
protozoan pathogens, such as Cryptosporidium and Giardia (Sobsey, 
1989). Alternative disinfection processes, ozone and ultraviolet light, are 
somewhat successful at destroying these pathogens. However, the 
processes do not always efficiently inactivate pathogenic viruses, 
because inactivation efficiency is dependant upon the viral species and 
turbidity level (Clancy et al., 2000) ( Sano et al., 2004). Moreover, new 
water treatment technologies are needed because discharge standards 




Coliphages are bacterial viruses that infect and replicate in 
Escherichia coli (E. coli). They are ubiquitous inhabitants of the intestinal 
tract of humans and animals and are encountered wherever fecal 
contamination occurs (Stetler et al., 1984). One type of coliphage that is 
commonly assayed for is MS2, a male specific coliphage from the family 
Leviviridae. MS2 is a coliphage that is often used as a model or surrogate 
to evaluate the presence of human viruses in water quality assessment, 
because it resembles enteric viruses more closely then the commonly 
used bacterial indicators of fecal pollution, such as coliforms and 
enterococci (Goyal and Gerba, 1983)(Grabow, 1996) (Vaughn and 
Metcalf, 1975). The MS2 virion is icosahedral in shape and consists of a 
protein coat containing a linear, single-stranded, RNA genome. MS2 
infects male E. coli cells via attachment to the F-pilus. After attachment, 
the phage genome enters the cell where it replicates exponentially, 
resulting in lysis of the bacterial cell (Cole et al., 2003). 
The size, structure, and survival rate of MS2 in the environment is 
similar to those of enteric viruses (Grabow, 1986). Laboratory experiments 
with individual coliphages have confirmed that many are more resistant 
to environmental stresses and survive longer in natural aquatic 
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environments than enteric viruses (Kott, 1984). Furthermore, these 
coliphages are at least as resistant, if not more resistant, to commonly-
used disinfectants, such as chlorine. In addition, MS2 is removed, from 
water, at comparable rates as enteric viruses, during treatment processes. 
Thus, male-specific RNA coliphages are useful surrogates for human 
enteric viruses in waters. 
Poliovirus 
Poliovirus is a small, 20 to 30 nm, single-stranded RNA virus belonging 
to the Picornaviridae family. It consists of non-enveloped particles which 
are comprised of a protein shell surrounding naked RNA genome. The 
poliovirus capsid is composed of 60 copies of 4 viral proteins (VP1, VP2, 
VP3, and VP4), which are arranged in an icosahedral symmetry. The 
surface of poliovirus has a corrugated topography with a prominent, star-
shaped plateau at the 5-fold axis of symmetry, surrounded by a deep 
depression and a protrusion at the 3-fold axis (Belnap et al., 2000). The 
poliovirus genome is a single-stranded, positive-sense RNA approximately 
7,440 nucleotides in length (Fields and Knipe, 1990). The plus-strand, 
genomic RNA functions as mRNA for viral protein expression and serves as 
a template for negative-strand RNA synthesis (Zhang and Racaniello, 
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1997). 
There are three types of poliovirus: 1, 2, and 3. Type 1 is the most 
virulent and the most common strain and type 3 is the second most 
common strain (Fields and Knipe 1990). Transmission of wild poliovirus 
ceased in the United States by 1979 (Strebel et al., 1992). Furthermore, as 
a result of an ongoing global vaccination campaign, type 2 poliovirus has 
not been detected anywhere in the world since 1999, (CDC, 2001). Both 
the Salk and Sabin poliovirus vaccines are trivalent vaccines, meaning 
that they are active against all three virus types. 
Humans are the only known reservoir of poliovirus, which is 
transmitted most frequently by persons with unapparent infections. 
Human-to-human transfer of poliovirus, via the fecal-oral route, is the most 
commonly implicated mode of transmission, although the oral-oral route 
may account for a small number of cases (Horstmann, 1967). Poliovirus 
enters through the mouth and primary multiplication occurs at the site of 
implantation in the pharynx or gastrointestinal tract. The virus is usually 
present in the throat and the gastrointestinal tract for a period of time 
before symptoms occur. The virus invades local lymphoid tissue, enters the 
blood stream, and then may infect cells of the central nervous system. 
Replication of poliovirus in motor neurons of the anterior horn and brain 
stem results in cell destruction and causes the typical manifestations of 
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poliomyelitis (Fields and Knipe, 1990). One week after onset, there is little 
virus residing in the throat, but virus remains in the gastrointestinal tract 
and continues to be excreted in the stool for several weeks. 
The response to poliovirus infection is highly variable and has been 
categorized based on the severity of clinical presentation; as many as 
95% of all polio virus infections are unapparent or asymptomatic. Infected 
persons without symptoms shed virus in the stool, possibly transmitting the 
virus to others. Approximately 4% to 8% of polio infections consist of a 
minor, nonspecific illness without clinical or laboratory evidence of central 
nervous system invasion. This clinical presentation is known as abortive 
poliomyelitis, and is characterized by complete recovery in two to three 
days. Three clinical manifestations associated with abortive poliomyelitis 
are upper respiratory tract infection, gastrointestinal disturbances, and 
influenza like illness. A complication of poliovirus infections, non-paralytic 
aseptic meningitis occurs in l%-2% of infected individuals. Typically 
symptoms from aseptic meningitis will last from 2 to 10 days, followed by 
complete recovery. Less than 1% of all polio infections result in flaccid 
paralysis. Paralytic symptoms generally appear 1 to 10 days after 
prodromal symptoms and progress for 2 to 3 days (Ryan, 1994). 
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Rotavirus 
Rotavirus is a member of the Reoviridae family. Rotaviruses are non-
enveloped, double-shelled, triple layered viruses. The nucleocapsid is 
isometric, with a non-occluded regular surface shape. Complete particles 
measure approximately 70 nm in diameter and have a distinctive double-
layered icosahedral smooth protein capsid that consists of an outer and 
an inner layer, when viewed by transmission electron microscopy (Fields 
and Knipe 1990). Within the inner capsid is a third layer, the core, which 
contains the virus genome consisting of 11 segments of double-stranded 
(ds) RNA (Ciarlet et al., 1998). The rotavirus genus is divided into seven 
antigenically distinct groups (A to G). Humans are susceptible to infection 
from Groups A, B, and C and animals are vulnerable to all groups. Four 
group A serotypes, (1, 2, 3 and 4), are of the greatest epidemiological 
importance because it is the leading cause of diarrhea in infants and the 
elderly (Estes and Cohen, 1989). Infection is primarily restricted to the villus 
epithelium of the small intestine, and the outcome of infection is age 
restricted (Fields and Knipe, 1990). 
Human rotavirus is considered the single most important cause of 
severe, potentially life-threatening, viral gastroenteritis and dehydrating 
diarrhea in young children worldwide. Each year, rotavirus causes 
7 
approximately 111 million episodes of gastroenteritis resulting in the need 
of home care, 25 million requiring clinic visits, and 2 million resulting in 
hospitalizations (Parashar et al., 2003). Worldwide, over 600,000 child 
deaths occur due to dehydration and electrolyte imbalance caused by 
rotavirus infection (Ciarlet et al., 2002). By age 5, nearly every child 
experiences an episode of rotavirus gastroenteritis; 1 in 5 will visit a clinic, 1 
in 65 will be hospitalized, and approximately 1 in 293 will die as result of 
complications from the infection. Children in underdeveloped countries 
account for 82% of rotavirus deaths (Parashar et al., 2003). 
The primary mode of transmission is the fecal-oral route; low titers of 
virus have been cultivated in respiratory tract secretions and other body 
fluids (Parashar et al., 2003). On a larger scale, rotaviruses have been 
documented as causative agents of waterbome disease outbreaks in the 
United States (Gerba, 2000). Waterborne disease outbreaks of rotavirus 
gastroenteritis can be attributed to their low infectious dose (1-10 
infectious units), ability to survive for extended periods of time in the 
environment (only 10% inactivation after 14 days at 23°C), and poor 
removal (21% to 27%) by some water treatment processes (Gratacap-
Cavallieretal., 2000) . 
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Adenovirus 
The Adenoviruses belong to the family Adenoviridae. They have an 
icosahedral structure and are of medium-size (90-100 nm). The particles 
are non-enveloped and the capsid is composed of 252 capsomeres, of 
which 240 are hexons and 12 are pentons (Fields and Knipe 1990). Each 
penton contains a base, which forms part of the surface of the capsid, 
and a projecting fiber, the length of which varies among the different 
serotypes (Norrby et al., 1976). The genome is 30,000-42,000 nucleotides 
long (Fields and Knipe, 1990). It is comprised of linear, monopartite, 
double-stranded DNA and is the only known waterbome human, double-
stranded, DNA virus. 
Adenoviruses were first discovered in 1953 in tonsil and adenoidal 
surgical specimens retrieved from children (Rowe et al., 1956). Similar viral 
agents were isolated from military personnel exhibiting a variety of 
respiratory illnesses (Hilleman and Werner, 1954). It was soon discovered 
that the viruses were antigenically related. Adenoviruses were first 
classified as adenoid degeneration viruses, adenoid-pharyngeal 
conjunctival viruses and acute respiratory disease viruses. Adenovirus was 
adopted as the family name in 1956 (Liu, 1991). Over 100 distinct 
serotypes are known to exist worldwide in humans, as well as in a variety 
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of animals. Fifty-one adenoviruses are currently recognized, which are 
classified into 6 subgenera (A through F) based on biochemical, 
immunological, and genetic parameters (Leclerc et al., 2002). 
Adenoviruses have been identified as a cause of waterborne 
illnesses in the United States as well as other countries (Leclerc et al., 2002), 
and several serotypes such as 1, 2, 5, and 6, are endemic in many parts of 
the world (Fields and Knipe, 1990). Although the epidemiologic 
characteristics of the adenoviruses vary by serotype, all are transmitted 
via direct contact, fecal-oral transmission, and occasionally waterborne 
transmission (Kukkula et al., 1997). Several serotypes are capable of 
establishing persistent asymptomatic infections in tonsils, adenoids, and 
intestines of infected hosts, and shedding can occur for a period of 
months to years (Fields and Knipe, 1990). Adenoviruses are typically stable 
when presented with chemical or physical agents and adverse pH 
conditions, allowing for prolonged survival outside of the body (Thurston-
Enriquez et al., 2003). As a result, adenoviruses are a substantial concern 
to public health and have been placed on the U.S. Environmental 




Disinfection is the primary mechanism for the inactivation and 
destruction of pathogenic organisms in water and wastewater. (USEPA, 
1999b). The goal is to prevent the spread of waterbome diseases to 
downstream users and the environment. Achieving this goal successfully 
requires choosing the appropriate disinfection process for a particular 
water or wastewater treatment facility, which is contingent on many 
factors. The disinfectant must be able to adequately disperse in or 
penetrate the water and destroy target organisms. Next, the disinfectant 
must be safe and simple to administer in quantities appropriate for the 
population density of the vicinity. Equally as important, use of the 
disinfectant must not result in toxic residuals or generation of carcinogenic 
or mutagenic byproducts. Lastly, the disinfection process must be 
relatively affordable to operate and maintain. The three most common 
types of disinfectants utilized in water and wastewater treatment facilities 
are chlorine, ozone and ultraviolet (UV) light. 
Chlorine Disinfection 
Chlorine is the most common disinfectant of wastewater in the 
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United States (USEPA, 1999a). It oxidizes cellular membrane material, by 
breaking unsaturated bonds, and has a moderate amount of nucleic 
acid activity affecting cellular respiration, transport, and DNA synthesis. 
Chlorine can be employed in many forms including chlorine gas, solid 
hypochlorite salts, and hypochlorite solutions. When chlorine is added to 
water, it undergoes hydrolysis and ionization until equilibrium is achieved 
(Bitton, 1980). 
Cl2 + H2O <-• HOCI + H+ + CI- (Hydrolysis reaction) 
HOCI «-• H+ + OCI- (Ionization reaction) 
The distribution of chlorine species is pH dependant. When the pH 
of water is less then 6.0, hypochlorous acid (HOCI) predominates. It is 70 to 
80 times more potent as a disinfectant than hypochlorite ions, the 
principal species when the pH is greater then 9.0 (USEPA, 1999a). Both 
forms are present at a pH between 6.0 and 9.0 (Bitton, 1980). 
Hypochlorous acid and hypochlorite ions are referred to as free chlorine. 
Total chlorine is composed of free chlorine and combined chlorine. 
Combined chlorine is formed when free chlorine coalesces with ammonia 
and nitrogenous compounds in the water (Haas, 1990). 
Chlorine disinfection has several advantages over other types of 
disinfection and is therefore used, the most commonly. It is a well 
12 
established technology which successfully inactivates a wide range of 
waterborne pathogens in a more cost-effective manner than ozone or UV 
light. Another advantage of using chlorine as a disinfect in drinking water 
facilities, is the fact that it leaves a residual in the water, long after initial 
dosing, which can be easily quantified and controlled (USEPA, 1999b). 
Maintaining a chlorine residual in a drinking water distribution system can 
help control biofilm growth and microorganism recontamination. There 
are, however, several disadvantages to using chlorine as a disinfectant, 
one being that chlorine is highly corrosive and toxic. In terms of water 
quality, high doses of chlorine can adversely affect taste and odor. The 
most severe disadvantage is the production of disinfection byproducts 
(DBPs). Disinfection byproducts, including trihalomethanes (THM) and 
haloacetic acids (HAA), form when organic matter combines with 
chlorine. Numerous toxicological studies have revealed that THMs and 
HAAs may be carcinogenic and teratogenic in laboratory animals (USEPA, 
2006a). 
Ozone Disinfection 
Ozone (O3), a powerful oxidant, is produced when oxygen (O2) 
dissociates, due to an energy source, into individual oxygen atoms (O) 
and subsequently collides with an oxygen molecule to form ozone (USEPA, 
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1999b). 
O2 + O <-+ O3 (Formation of ozone) 
Ozone is extremely unstable and must be produced immediately 
prior to use. Most treatment plants generate ozone by imposing a high 
voltage alternating current across an electric discharge gap that contains 
an oxygen-bearing gas (USEPA, 199b). When ozone decomposes in 
water, free radicals such as hydrogen peroxy and hydroxyl are formed. 
These free radicals have strong oxidizing abilities and play an active role in 
the disinfection process. The primary inactivation mechanism of ozone is 
oxidation and disruption of glycoproteins and glycolipids on the outer 
membrane orcapsid of the pathogen (USEPA, 199b). 
Disinfection of water using ozone has several advantages including 
short contact time and elevated oxygen concentration. In addition, 
ozone disinfection is more effective than chlorine in inactivating viruses 
and bacteria (Finch and Fairbaim, 1991). Some disadvantages of using 
ozone as a disinfectant include high financial expense, possible irritation 
and toxicity, and the formation of disinfection byproducts, when 
combined with inorganic and organic compounds normally found in 
water. These DBPs include aldehydes, carboxylic acids and bromate 
(USEPA, 1999b). 
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Ultraviolet Light Disinfection 
UV disinfection is a physical disinfection process and does not 
require the addition of chemicals to water like chlorine and ozone 
disinfection. The optimum wavelength of UV light to effectively inactivate 
microorganisms ranges between 240 to 280 nm (USEPA, 1999b). UV light is 
produced by applying an electrical discharge through mercury vapor. It 
inactivates pathogens by the adsorption of radiation, which causes a 
photochemical reaction involving nucleic acid and other internal 
components. This often causes viral destruction via dimerization of 
pyrimidine molecules, which results in an inability of the cell or virion to 
replicate its genetic material. 
UV light disinfection has numerous advantages including efficient 
inactivation of bacteria, viruses, and protozoans (USEPA, 1999b). In 
addition, UV disinfection is a physical process rather than a chemical 
process, which eliminates transportation, storage and hazardous 
management requirements, which are present with ozone and chlorine 
disinfection. Finally, UV light does not leave a residual nor does it produce 
DBPs. Disadvantages of UV light disinfection are as follows: high capital 
and maintenance costs when compared to chlorine disinfection and 
occasional repair and reversal of the destructive effects of UV light by 
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microorganisms through a repair mechanism known as photo 
reactivation, or in the absence of light, dark repair (USEPA, 1999b). 
UV radiation quickly dissipates in water by either absorption or 
reflection, therefore no residual is produced. As a result, no DBPs are 
formed; however, a secondary disinfectant is necessary to maintain a 
disinfectant residual throughout the water distribution system. 
Disinfection Byproducts 
Disinfection byproducts (DBPs) are formed when disinfectants, such 
as chlorine and ozone, combine with naturally occurring organic and 
inorganic substances present in water. Recent studies link DBPs to 
reproductive and developmental abnormalities such as stillbirth (King et 
al., 2000), spontaneous abortion (Waller et al., 1998), low birth weight 
(Dodds et al., 1999) and various birth defects (Yang et al., 2000). In 
addition, epidemiology and toxicology studies have implicated the 
consumption of DBPs in the formation of bladder, rectal, and colon 
cancers (USEPA, 2006a). 
DBPs are classified into four categories including disinfectant 
residuals, inorganic byproducts, organic oxidation byproducts, and 
halogenated organic byproducts (USEPA, 1999b). In the United States, 
over 260 million individuals are exposed to DBPs in drinking water. The 
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Stage 1 Disinfection Byproduct Rule (DBPR) is an amendment to the 1989 
Surface Water Treatment Rule (SWTR), enacted by the EPA, in order to limit 
the amount of disinfection residual and DBPs in water treatment plant 
distribution systems. The Stage 1 DBPR, finalized in December 1998, is the 
first phase of risk reduction concerning DBPs. The Stage 1 DBPR applies to 
community water systems (CWS) and non-transient non-community water 
systems (NTNCWS). CWS are public water systems that serve residents of 
communities with at least 15 service connections or 25 residents year-
round. A NTNCWS is a water system that serves facilities such as schools or 
businesses, utilized by at least 25 of the same people, for more then six 
months out of the year (USEPA 1999b). The Stage 1 DBPR requires a 
running annual average of DBP across the entire water treatment system. 
The Stage 2 DBPR went into effect on March 6, 2006 as a 
supplement of previous regulations to reduce risks of DBPs. The Stage 2 
DBPR requires that CWS and NTNCWS perform an evaluation of their 
distribution system and identify the locations where DBPs are elevated. 
The locations which are deemed high risk will be used as sampling sites for 
Stage 2 DBPR monitoring. Maximum contaminant levels (MCLs) for two 
groups of DBPs, total trihalomethanes (TTHM) and haloacetic acids 
(HAA5), are established by the Stage 2 DBPR. The MCL, as regulated by 
the Stage 2 DBR, for TTHM and HAA5 are 0.080 mg/L and 0.060 mg/L 
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respectively (USEPA, 2006a). Total trihalomethanes and HAA5 are two 
commonly occurring classes of DBPs formed due to chlorine disinfection 
of water. Because these two classes of DBPs generally occur at higher 
levels than other DBPS, they are meant to serve as DBP indicators. 
There are many factors that affect the formation of DBPs including 
pH, temperature, organic and inorganic material, and bromide ion. 
Halogenated DBPs are formed when a strong oxidant, such as chlorine or 
ozone, react with organic matter or free bromine. Non-halogenated DBPs 
are formed when strong oxidants reacts with inorganics present in water. 
The EPA has recognized the effect of DBPs long before laws were 
enacted to monitor their presence in public water sources. In 1983, the 
EPA recognized treatment techniques which would reduce the 
production of DBPs. One of the primary methods for reducing DBPs 
involves the removal of DBP precursors through improved flocculation and 
coagulation processes (Nieuwstad et al., 1988). 
Hiah Gradient Magnetic Separation 
One method of effectively removing a variety of substances from 
water is through high gradient magnetic separation (HGMS). This method 
requires the separation of weakly magnetic and non-magnetic particles. 
HGMS can be facilitated by the addition of particles with a high magnetic 
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susceptibility to form aggregates of diamagnetic particles. The 
diamagnetic particles can then be removed by a type of magnetic 
filtration termed high gradient magnetic separation (HGMS) (Ying et al., 
2000). High gradient magnetic separation was first introduced as a 
mitigation and recovery process for several industrial and environmental 
applications (Yiacoumi et al., 1996). The differences of the magnetic 
susceptibility of materials determines their recovery from water or removal 
as a waste product. The principles of HGMS are summarized in the 
formula below: 
FM= MOVH (dH/dx) 
Where : FM = magnetic force on a particle in a magnetic field 
Ho = magnetic susceptibility 
V= volume of the particle 
H = background magnetic field 
(dH/dx) = magnetic field gradient 
The theory for particle separation is to create a high gradient 
magnetic field (M) within a background field (H). The background field 
interacts with moving electric charges; the forces on ions of opposite 
charges occur in opposite directions. The redirection of the particles 
increases the frequency with which ions collide and combine. 
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According to the above equation, to increase the force of a 
particle (FM) material the background magnetic field may be increased 
by using stronger electromagnets, however, the cost for powerful 
electromagnets is high. The magnetic field gradient (dH/dx) can be 
increased by incorporating a field matrix, but the operation and 
maintenance cost is not economical. The least expensive and most 
convenient way to increase the Fm is to increase the magnetic 
susceptibility (|Jo) by adding a hetero-coagulant such as magnetite. 
Current uses of HGMS include the removal of phosphate from 
water, beneficiation of low grade iron ores, kaolin clay refinement, 
desulphurization of coal, filtration of nuclear waste coolant, recovery of 
hematite and chromite from water, and removal of algae, yeast, and 
bacteria from wastewater (Bitton et al., 1974) (Terashima et al., 1986) 
(Parker, 1981)(Ying et al., 1999) (Wang et al., 1994) (Bitton and Mitchell, 
1974). 
All particles can be divided into three categories on the basis of 
their magnetic susceptibility; the ratio of the degree of magnetization to 
the applied magnetic field strength. These categories include: 1) 
Ferromagnetic materials, which have a high positive magnetic 
susceptibility of one, 2) Paramagnetic materials, which have a weak 
positive magnetic susceptibility of 103 to 105 and 3) Diamagnetic 
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materials, which have a negative magnetic susceptibility of 1 x 105 (Tsouris 
and Yiacoumi, 1997). Examples of ferromagnetic materials are iron, 
nickel, gadolinium and magnetite. These materials have very strong 
responses to a magnetic field: they become strongly polarized in the 
direction of the magnetic field. More importantly, they retain at least 
some of their polarization after the magnetic field is removed. Once 
ferromagnetic materials are polarized they produce a magnetic field of 
their own. Since these fields are usually not uniform, particularly near the 
ends, ferromagnetic materials are capable of attracting each other and 
other weakly magnetic particles. 
Paramagnetic materials include sodium, oxygen and platinum. 
They are affected, somewhat less strongly than ferromagnetic materials, 
and are weakly polarized parallel to a magnetic field. Thus, in a non-
uniform magnetic field, they undergo a force towards the higher 
magnetic field region. However, unlike ferromagnetic materials, 
paramagnetic materials do not produce a magnetite field of their own in 
the absence of an externally applied magnetic field. 
Diamagnetic materials such as copper, lead, quartz, water, 
acetone, and carbon dioxide are very weakly affected by magnetic 
fields. They become magnetically polarized in the direction opposite of 
the magnetic field. If the magnetic field is not uniform, they follow a force 
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away from the higher field region. Diamagnetism results from the effects 
of magnetic fields on all of the electrons in the material. Thus, all materials 
have a diamagnetic response. However, the other forms of magnetism 
are stronger than diamagnetism; therefore the diamagnetism is often 
ignored, unless it is the only magnetic effect present. 
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Figure 1: Response of paramagnetic and diamagnetic materials to a 
magnetic field (H). 
Figure 2: Response of ferromagnetic materials to a magnetic field (H). 
Figures 1 and 2 adapted from: Physics for Scientists and Engineers by R.A 
Serway, and J.W. Jewett. 
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Magnetite 
Magnetite is a ferromagnetic, cubic mineral with the chemical 
formula [Fe3+]lv[Fe2+Fe3+]vl04. The International Union of Pure and Applied 
Chemistry (IUPAC) name for magnetite is iron (II, III) oxide and the 
common name is ferrous-ferric oxide. Magnetite is the most magnetic of 
all the naturally occurring minerals on Earth (Moore, 2007). It is a member 
of the inverse spinel structure type of which half the ferric ion is 
tetrahedrally coordinated and the remaining portion, as well as the total 
ferrous iron, is octahedrally coordinated by cubic closed packed oxygen 
ions. Magnetite is iron black and opaque in color. The hardness is a 6 on 
the Mohs scale and the specific gravity is 5.20. Magnetite occurs in the 
granular or massive form, most commonly as a magmatic segregation in 
basic rocks. However, it is also chemically produced (Karapinar, 2003). It 
is most abundant naturally in Sweden, Norway, Russia and Canada but 
also can be found as an accessory mineral in igneous rocks throughout 
the world (Moore, 2001). Hydrolysis of magnetite produces a highly 
hydroxylated surface where a charge is generated by the addition of 
acidic or alkaline solution. This process is summarized in the following 
reversible equation (Bolto and Spurling, 1991): 
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V ~.. H V *,, OK" V ^ Fe-OH ^ = ^ Je-OHo ^ = ^ Fe-O" 
/ / / 
The isoelectric point of magnetite is 7.5 ± 0.5 therefore, under acidic 
conditions, the surface of magnetite will carry a net positive charge 
attracting negatively charged material. When the pH is raised to alkaline 
conditions, the surface of magnetite becomes negatively charged and 
any previously negatively charged material is repelled. Therefore, 
because of the magnetic properties of magnetite, at an acidic pH, it 
functions as an adsorbent for colloids, organic materials, bacteria and 
viruses (Anderson et al., 1982). 
The first reported application, employing magnetite to concentrate 
viruses, was reported by Warren et al. using myxoviruses (Warren et al., 1966). 
In later research, Rao et al. utilized magnetite to concentrate enteric viruses in 
drinking water (Rao et al., 1981). Further research projects, used magnetite 
as an adsorbent to remove a variety of contaminants from wastewater 
including: T7 bacteriophage, coliform bacteria, suspended solids and 
algae (Bitton et al., 1974)(de Latour, 1973) (Bitton et al., 1974). Previous 
research has also investigated the effects of magnetite and poliovirus 
type 1 in a wastewater matrix (Bitton, 1976). This research, demonstrated 
that magnetite was an effective adsorbent for poliovirus type 1, resulting 
in up to 99.8% removal. 
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CoMaq™ 
The traditional approach to wastewater treatment includes 
biological treatment, such as trickling filters, biofilms, and activated 
sludge, which convert organics in the wastewater into sludge and CO2 
(Booker et al., 1990). Although these biological processes have been an 
adequate means of wastewater treatment, they are intrinsically limited by 
their biological nature, illustrated by the fact that they require expertise to 
conduct and maintain due to their sensitive nature and susceptibility to 
bactericidal contaminants in wastewater. Consequently, establishing 
biological processes is expensive and difficult, compared to applying 
conventional, physio-chemical, methods of wastewater treatment such as 
flocculation and coagulation techniques. 
Although presented as a more feasible option than biological 
processes to treat wastewater, physio-chemical processes also have 
significant shortcomings. Some disadvantages of conventional physio-
chemical wastewater treatment methods include the high cost of 
chemicals and the formation of large amounts of gelatinous sludge 
(Booker et al., 1990). The CoMag™ process is an enhanced magneto-
chemical process that attempts to solve the limitations of current physio-
chemical and biological wastewater treatment processes by improving 
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aspects of coagulation and solids separation. In addition, the CoMag™ 
process provides a flow rate several times faster then conventional flow rates. 
This advantage results in a smaller space requirement necessary for 
wastewater treatment to occur. 
The CoMag™ technique begins with passing influent wastewater 
through a pre-conditioning magnetic matrix, prior to precipitation. This step 
creates a locally induced magnetic moment, which is sensed by the colloidal 
particles. Colloids will not settle when they are suspended in a liquid. The 
electrostatic charges on each particle prevent the colloids from 
aggregating. Also, the thermal motion of each particle offsets its 
gravitational potential energy (Kolm et al., 1975). When HGMS is applied 
to colloidal particles suspended in water, there are many forces acting on 
them, including attractive van der Waals forces, repulsive electrostatic 
forces, and hydrodynamic forces due to water properties and magnetic 
moments between permanent or induced magnetic moments (Tsouris et 
al., 1995). In theory, when the strength of the applied high gradient 
magnetic field is greater than the thermal motion of the colloid, the 
magnetic force created by the field is large enough to increase the 
magnetization of the colloid resulting in greatly enhanced precipitation. 
After passing through the preconditioning magnet, aluminum sulfate 
and polymer are mixed with wastewater, in a series of tanks, allowing for 
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maximum coagulation and flocculation. Coagulation or destabilization of a 
colloidal suspension, results in the combination of minute particles by physical 
and chemical processes and flocculation causes the formation of a larger 
settleable structure by bridging. Aluminum potassium sulfate, alum, provides 
the necessary coagulation electrolyte, Al+3, which creates a strong bond 
between the magnetite seed and the contaminants. The aluminum 
cation in solution is coordinated into six ligand ions, forming a metal ion 
hydrolysis complex (de Latour, 1973). The nature of this complex is 
dependant on the environment, especially pH. Depending on the 
nucleation step, floe formation of AI(OH)3 may proceed along two 
different pathways; homogeneous and heterogeneous. Homogeneous 
growth occurs in the absence of an initial surface site and proceeds as 
small precipitates of AI(OH)3 serve as the nucleation site for growth. In 
contrast, heterogeneous growth begins in the presence of a seed (Kuo et 
al., 1998). When alum is added to a contaminated solution, the solid 
surfaces of the contaminants become coated with aluminum hydrolysis 
complexes creating a "fluff" around the contaminant (de Latour, 1973). 
Alum may aid in coagulation in two ways (Cohen et al., 1971). First, the 
"fluff" formed around each particle can enlarge through the process of 
aluminum bridging. Second, the surface charge of the particle is altered 
when the aluminum hydrolysis complex is adsorbed to its surface. In all but 
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strongly alkaline solutions, the complex is positively charged. Considering 
that most waterborne contaminants are negatively charged the 
reduction of the surface charge of the contaminants make coagulation 
achievable. 
A nucleation aid, such as bentonite, is then added to increase floe size 
and weight. Studies have revealed that virus adsorption to bentonite and 
other clays are significant and increase in the presence of a trivalent 
cation, such as aluminum sulfate (Carlson et al., 1968)(Schaub et al., 
1974). Fine magnetite powder is also added at this stage to increase floe 
density and allow for floe removal using a magnetic separator. Magnetite 
displays a net positive charge in an acidic environment and this enables the 
negatively charged viruses to attach to the magnetite surface. The tiny 
magnetite particles are enmeshed into the floe and function as magnetic 
handles. The flocculated solids settle very rapidly in a small clarifier that 
operates at an overflow rate, over 10 times that which is typical for standard 
physio-chemical processes. A portion of the solids underflow, approximately 
80 percent, is recirculated to the first stage contact basin, while the remaining 
portion is removed as sludge. The clarified effluent passes through a 
magnetic separator in a final polishing stage to remove microflocs that 
escaped the clarifier. Magnetite is recovered from the sludge in a magnetic 
drum separator and recycled to the magnetite feed tank for reuse. The 
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sludge is removed from the system and ultimately disposed of with the 
remainder of the plant sludge produced during biological treatment. 
The primary difference between the CoMag™ process and other 
conventional technologies occurs during the removal stage. Since 
magnetite creates a denser floe, the flocculated particles settle more 
rapidly. For that reason, the clarifier is many times smaller than 
conventional clarifiers and settling occurs much quicker. Other major 
benefits include the removal of pin floe, with a magnetic separator, and 
the magnetite seed can be recovered from the sludge using a magnet 
instead of gravity. 
Concord MA Wastewater Treatment Facility 
The Concord Wastewater Treatment Facility (WWTF) was built in 
1986 and treats 1.2 million gallons of wastewater per day, according to 
monthly average discharge flow. The effluent discharges to the Concord 
River. Treatment through the Concord WWTF currently consists of 
headworks, primary settling, single stage trickling filters run in parallel, 
secondary clarification, intermittent sand beds for winter season polishing, 
and chlorine disinfection. 
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Figure 3: Flow diagram for the Concord, MA Wastewater Treatment 
Facility and CoMag ™ wastewater treatment process. 
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Adapted from: Cambridge Water Technology. 2007. 
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Adapted From: USEPA (United States Environmental Protection Agency). 
2007. 
32 
Research Objectives and Technical Approach 
Research Objectives 
The research objectives of this project were to develop and 
evaluate a bench scale model of an enhanced magneto-chemical 
water treatment process called CoMag™ for the removals of MS2, 
poliovirus type 1, rotavirus stain Wa and adenovirus type 2. Secondary 
effluent obtained from the Concord, MA Wastewater Treatment Plant was 
the matrix evaluated for the removals of MS2, poliovirus type 1, rotavirus 
strain Wa and adenovirus type 2 using the bench scale model of the 
CoMag™ process. Bench scale experiments were conducted at room 
temperature (24°C) and at a reduced temperature (4°C) to represent the 
temperature conditions encountered in New England. The 100 gpm 
CoMag™ pilot plant was then challenged with MS2 coliphage. The data 
that was generated from the bench scale and pilot plant studies was 
used to develop a correlation of the removal of MS2 to the removals of 
poliovirus type 1, rotavirus strain Wa and adenovirus type 2. 
Technical Approach 
1. Evaluate the removal of MS2 using a bench scale model of the 
CoMag™ process. 
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The removal of MS2 using a bench scale model of fhe enhanced 
magneto-chemical water treatment process was evaluated at 
room temperature (24°C) and then at a reduced temperature 
(4°C). 
2. Evaluate the removal ofpoliovirus type 1 and MS2 using a bench scale 
model of the CoMag™ process. 
The removal of MS2 and poliovirus type 1 using a bench scale 
model of the CoMag™ process was evaluated at room 
temperature (24°C) and then at reduced temperature (4°C). A 
one-way unstacked ANOVA was performed to evaluate the 
following null hypotheses: (1) there is no statistically significant 
difference between the removals of poliovirus type 1 at 24°C and 
4°C (2) there is no statistically significant difference between the 
removals MS2 and poliovirus type 1 at 24°C and 4°C. A p value of 
O.05 was used as a parameter for statistical significance. 
3. Evaluate the removal of rotavirus strain Wa and MS2 using a bench 
scale model of the CoMag™ process. 
The removal of MS2 and rotavirus strain Wa using a bench scale 
model CoMag™ process was evaluated at room temperature 
(24°C) and then at a reduced temperature (4°C). A one-way 
unstacked ANOVA was performed to evaluate the following null 
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hypotheses: (1) there is no statistically significant difference 
between the removals of rotavirus strain Wa at 24°C and 4°C 
(2) there is no statistically significant difference between the 
removals MS2 and rotavirus strain Wa at 24°C and 4°C. A p value of 
O.05 was used as a parameter for statistical significance. 
4. Evaluate the removal of adenovirus type 2 and MS2 using a bench 
scale model of the CoMag™ process. 
The removal of MS2 adenovirus type 2 using a bench scale model 
of the CoMag™ process was evaluated at room temperature 
(24°C) and then at a reduced temperature (4°C). A one-way 
unstacked ANOVA was performed to evaluate the following null 
hypotheses: (1) there is no statistically significant difference 
between the removals of adenovirus type 2 at 24°C and 4° C 
(2) there is no statistically significant difference between the 
removals MS2 and adenovirus type 2 at 24°C and 4°C. A p value of 
O.05 was used as a parameter for statistical significance. 
5. Perform statistical analysis and correlate the removal of MS2 with the 
removals ofpoliovirus type 1, rotavirus strain Wa and adenovirus type 2. 
Statistical analysis of triplicate trials was performed using Minitab version 
15 to evaluate the removals of MS2 in the following experiments: MS2 
alone with and without magnetite, MS2 and poliovirus type 1, MS2 and 
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rotavirus strain Wa and MS2 and adenovirus type 2 at 24°C and 4°C. 
An one-way unstacked ANOVA was performed to evaluate the 
following null hypotheses: (1) there is no statistically significant 
difference between the removals of MS2 when in the presence of 
poliovirus type 1, rotavirus strain Wa or adenovirus type 2 when 
compared to the removal of MS2 alone at 24° (2) there is no 
statistically significant difference between the removals of MS2 
when in the presence of poliovirus type 1, rotavirus strain Wa or 
adenovirus type 2 when compared to the removal of MS2 alone at 
4°C. A p value of <0.05 was used as a parameter for statistical 
significance. 
6. Challenge the CoMag™ process pilot plant with MS2. 
An existing full-process 100 gallon per minute commercial 
demonstration pilot plant was challenged with MS2 at a final 
concentration of 1 x 105 PFU/mL three times. A two-way ANOVA 
was performed to evaluate the following null hypotheses: (1) the 
CoMag™ pilot plant does not have a statistically significant effect 
on the removal of MS2. A p value of O.05 was used as a parameter 
for statistical significance. 
7. Compare the results for the removal of MS2 at the CoMag ™ pilot 
plant to the removal of Ms2 obtained using the bench scale model 
of CoMag™ process. 
A one-way unstacked ANOVA was performed to evaluate the 
following null hypothesis: (1) there is no statistically significant 
difference between the removal of MS2 at the pilot plant and the 
removal of MS2 using a bench scale model of the CoMag™ process. 




MATERIALS AND METHODS 
MS2 Propagation and Enumeration 
MS2 (ATCC 1597-B1) was prepared and quantified using a modified 
double agar overlay method adapted from protocol established by 
DeBartolomeis and Cabelli (DeBartolomeis and Cabelli, 1991). A mutant 
strain of E. coli HS (pFamp) R served as the host organism. In addition to 
displaying a resistance marker to ampicillin on the F plasmid, the selected 
host strain is resistant to somatic coliphages T2 to 17 and OX174, 
streptomycin, and naladixic acid, (Cho, 2005). 
In order to propagate MS2, the E. coli HS (pFamp) R host was grown, 
with gentle agitation, to log phase in Tryptic Soy Broth (TSB) 
supplemented with 1% streptomycin, 1% ampicillin, and 0.5 % magnesium 
chloride at 37°C for approximately three hours. MS2 bacteriophage was 
then added to log phase host culture and incubated statically at 37°C for 
12 to 18 hours. Subsequent to incubation, the E. coli and MS2 suspension 
was centrifuged at 10,000 rpm, at 4°C, for ten minutes. The supernatant 
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was removed and filtered using a 0.22 pm filter to remove bacteria and 
cellular debris. The filtrate was then placed in sterile bottles and 
refrigerated at 4°C, until use. 
As previously mentioned, the MS2 was enumerated using a 
modified double-agar overlay technique in which E. coli HS (pFamp) R 
acted as the host (DeBartolomeis and Cabelli, 1991). The E. coli host was 
grown to log phase in TSB supplemented with 1% streptomycin, 1% 
ampicillin, and 0.5 % magnesium chloride at 37°C for approximately three 
hours. Serial dilutions of the sample were prepared using Phosphate 
Buffered Saline. Five mL of soft agar overlay was inoculated with 100 ul of 
the appropriate dilution and 200 ML ° f 'og phase E. coli. Each sample 
was gently swirled and poured onto a 1.5% Tryptic Soy Agar (TSA) 100 mm 
plate supplemented with 1% streptomycin and 1% ampicillin, followed by 
an overlay. The plates were inverted and incubated at 37°C for 18 to 24 
hours. Each plate was examined for plaques and those containing 30 to 
300 plaques were used to calculate the titer of the sample. The final titer 
of the sample was recorded as plaque forming units per mL (PFU/mL). 
Poliovirus Propagation and Enumeration 
Poliovirus type 1 LSc was propagated on Buffalo Green Monkey 
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Kidney (BGMK) cells, a continuous African monkey kidney cell line (WHO, 
1997). Poliovirus LSc is a variant of the Mahoney strain of Poliovirus. The 
Mahoney strain was isolated by T. Francis, in 1941, from a composite of 3 
stools collected from asymptomatic patients with poliomyelitis in 
Cleveland (Li, 1955). 
The BGMK cells were grown in Eagle's Minimal Essential Media 
(MEM), supplemented with L-15 and 5% Fetal Bovine Serum (FBS). For 
poliovirus propagation, BGMK cells were grown to 90% confluency, in 
closed 75 cm2 cell culture flasks at 37°C, with 15 mL of MEM. The 
confluent monolayers of BGMK cells were inoculated with 100 pL of 
poliovirus type 1 and incubated at 37°C for 90 minutes, with rocking every 
15 minutes, to facilitate viral adsorption and maintain hydrated cells. One 
75 cm2 cell culture flask was inoculated with 100 |jL of warm serum-free 
MEM to act as the negative control. 
Following incubation, 15 mL of a maintenance media consisting of 
MEM supplemented with L-15 and 2% FBS was added to all flasks and the 
cells were incubated at 37°C. The flasks were observed daily for evidence 
of cytopathic effects (CPE). Once 90% CPE was observed, flasks were 
frozen at -80°C and rapidly thawed at 37°C. This freeze/thaw process was 
repeated three times to completely lyse the cells and facilitate viral 
release. The cell lysates were then centrifuged at 1000 x g for ten minutes 
40 
to pellet cellular debris. Then the supernate was filtered with a 1 % FBS 
pretreated 0.22 |jm PVDF filter. The filter was pretreated to reduce the 
adsorption of virus to the filter. Virus was stored at 4°C for short term 
storage and -80°C for long term storage. 
Enumeration of the virus was performed using a modified neutral 
red plaque-forming unit (PFU) method (Dulbecco and Vogt, 1953). BGMK 
cells were grown to 90% confluency in closed 25 cm 2 culture flasks, 
supplemented with 5% FBS. The cells were washed three times with serum-
free MEM. Virus to be analyzed was serially diluted in serum-free MEM and 
closed 25 cm 2 culture flasks were inoculated, in triplicate, with 100 |JL of 
the appropriate poliovirus dilution. The flasks were then incubated at 37°C 
for 90 minutes, with rocking every 15 minutes, to facilitate viral adsorption 
and maintain hydrated cells. Following adsorption 10 mL of medium 
consisting of MEM supplemented 2% FBS, 2% flake agar (Difco), and 
neutral red (Sigma) was added. This overlay provides a solid support 
matrix to physically confine the virus as well as a viability stain to observe 
plaque formation. 
Flasks were then inverted and incubated at 37°C and observed for 
plaques every 24 hours, for up to seven days. Only plates containing 20 
to 50 plaques were counted. Plaques were quantified and PFU/mL was 
determined. Enumerated poliovirus stocks were stored at -80°C, until 
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needed for bench scale CoMag™ challenges. 
Rotavirus Propagation and Enumeration 
Rotavirus strain Wa (Tissue Culture adapted) (ATCC, VR-2018) 
propagation and enumeration was accomplished using modified 
protocols established by Smith et al. (Smith, 1979). Rotavirus was 
propagated on MA-104 (ATCC, CRL-2378.1), an embryonic Rhesus 
monkey kidney cell line. MA-104 cells were grown in Eagle's MEM 
supplemented with L-15 and 10% Fetal Bovine Serum (FBS). For rotavirus 
propagation, MA-104 cells were grown to 90% confluency, in closed 75 
cm2 cell culture flasks at 37°C, in 15 mL of MEM, supplemented with L-15 
and 10% FBS. Ninety percent confluent monolayers of MA-104 cells were 
inoculated with 100 pL of rotavirus strain Wa and incubated at 37°C for 90 
minutes, with rocking every 15 minutes, to facilitate viral adsorption and 
maintain hydrated cells. One 75 cm2 cell culture flask was inoculated with 
100 pL of warm serum-free MEM to serve as the negative control. 
Following incubation, 15 mL of a maintenance media, consisting of 
MEM supplemented with L-15 and 2% FBS, was added to all flasks and the 
cells were incubated at 37°C. The flasks were observed daily for evidence 
of CPE. Once 90% CPE was observed, flasks were frozen at -80°C and 
42 
rapidly thawed at 37°C, three times, to completely lyse the cells and 
facilitate viral release. The cell lysates were then centrifuged at 1000 x g 
for 10 minutes to pellet cellular debris. The supernatant was filtered with a 
1 % FBS pretreated 0.22 pm PVDF filter. Virus was stored at 4°C for short 
term storage and at -80°C for long term storage. 
Rotavirus strain Wa was enumerated using a modified plaque-
forming unit (PFU) method (Smith, 1979). MA-104 cells were grown to 90% 
confluency, in closed 25 cm 2 culture flasks, supplemented with 10% FBS. 
All cells were washed three times with serum-free MEM. Virus to be 
analyzed was serially diluted in serum-free MEM and closed 25 cm 2 culture 
flasks were inoculated, in triplicate, with 100 |JL of the appropriate rotavirus 
dilution. 
The flasks were then incubated at 37°C, for 90 minutes, with rocking 
every 15 minutes to facilitate viral adsorption and maintain hydrated cells. 
Following adsorption, 10 mL of medium, consisting of equal portions of 2X 
MEM, supplemented with 1 mg/mL of trypsin (Gibco) and 2.4% agar 
(Sigma), was added. 
Flasks were then incubated at 37°C for four days. Following 
incubation, 2 mL of 10% formaldehyde, in normal saline solution, was 
added to each flask. The flasks were then returned to the 37°C incubator 
overnight. Upon removal from the incubator, the solid overlays were 
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removed from the flasks using warm tap water. Two mL of a 0.1% crystal 
violet solution was added to each flask to permit contrast between live 
MA-104 cells and plaques. Plaques were quantified and a PFU/mL value 
was determined. Enumerated rotavirus stocks were stored at -80°C, until 
retrieved for bench scale CoMag™ challenges. 
Adenovirus Propagation and Enumeration 
Adenovirus type 2 (ATCC, VR-846) was propagated and 
enumerated in A549 (ATCC, CCL-185), a continuous human lung cell line 
as previously described by Wold (Wold, 1999). A549 cells were grown in 
Eagle's MEM, supplemented with L-15 and 10% FBS. For adenovirus 
propagation, A549 cells were grown to 90% confluency, in closed 75 cm 2 
cell culture flasks at 37°C, in 15 mL of MEM supplemented with L-15 and 
10% FBS. Confluent monolayers of A549 cells were inoculated with 100 (jL 
of adenovirus type 2 and incubated at 37°C for 90 minutes, with rocking 
every 15 minutes, to facilitate viral adsorption and maintain hydrated 
cells. One 75 cm 2 cell culture flask was inoculated with 100 |jL of warm 
serum-free MEM, which served as the negative control. Following 
incubation, 15 mL of a maintenance media, consisting of MEM 
supplemented with L-15 and 2% FBS, was added to all flasks, which were 
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incubated at37°C. 
The flasks were observed daily for evidence of CPE. Once 90% CPE 
was observed, the flasks were frozen at -80°C and rapidly thawed at 37°C, 
three times, to completely lyse the cells and facilitate viral release. The 
cell lysates were then centrifuged, at 1000 x g for ten minutes, to pellet 
cellular debris. The supernatant was filtered with a 1% FBS pretreated 0.22 
|jm PVDF filter. Virus was stored at 4°C, for short term storage, and at -
80°C for long-term storage. 
Adenovirus type 2 was enumerated using the Tissue Culture 
Infective Dose 50 (TCID50) method (Meng, 1996). A549 cells were grown in 
96 well cell culture plates, at 37°C and 5% CO2, until 90% confluency was 
achieved. Virus to be analyzed was serially diluted in serum-free MEM and 
25 JJL of the viral dilution was inoculated into 10 wells, in triplicate. 
Negative wells contained 25 |jL of serum-free MEM. The plates were then 
incubated, for 90 minutes at 37°C and 5% CO2, followed by an addition of 
200 u i MEM, supplemented with L-15 and 2% FBS. The plates were 
incubated at 37°C and 5% CO2 for ten days. 
Cells were observed daily for evidence of CPE. Wells which 
exhibited CPE within ten days were recorded as positive and wells not 
displaying CPE were recorded as negative. The number of positive and 
negative wells were then referenced to calculate the TCID50 value, using 
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the Reed and Muench method illustrated below (Reed, 1938). 
Calculation of TCID50: 
Log TCID50/ mL = log [{10 exp [X + (p - 0.5)]} / inoculum 
volume] 
Where: X = positive exponent from last dilution where all wells 
are positive 
p = ratio of positive wells/ total number of wells 
Sample Collection 
All CoMag™ bench scale experiments were conducted using 
secondary effluent from the Concord Wastewater Facility in Concord, 
MA. The secondary effluent was sampled after trickling filter treatment of 
the wastewater, but before chlorine disinfection. An adequate amount of 
secondary effluent was collected, in one visit, to conduct all CoMag™ 
bench scale challenges and stored at 4°C; this minimized variation of 
results and allowed for comparison of all data produced by the bench 
scale model. 
Bench Scale Experiments 
All bench scale experiments were performed using a Phipps and 
Bird ™ 6- paddle Jartester. 
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Figure 5: Phipps and Bird ™ 
top experiments. 
6- paddle Jartester used for bench -
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MS2 
The removal of MS2, using a bench scale model of the CoMag™ 
process, without added magnetite and at room temperature (24°C), was 
evaluated. In addition the removal of MS2, using a bench scale model of 
the CoMag™ process, was evaluated at room temperature (24°C) and 
then at a reduced temperature (4°C). All trials were performed in 
triplicate. Initial CoMag™ bench scale trials were performed using MS2. 
One thousand milliliters of secondary effluent was placed into five sterile 
1200 mL beakers. Two of the beakers functioned as controls, with one of 
the controls consisting of secondary effluent with MS2, spiked to a final 
concentration of 1 x 105 PFU/mL, with no chemicals added. The purpose 
of this particular control was to reveal any removal or inactivation of MS2 
because of rapid stirring with the six-paddle jartester, settling during the 
quiescent step, toxins in the wastewater, or other nonspecific methods. 
The second control contained only 1000 mL of secondary effluent and the 
appropriate chemicals. The purpose of this control was to reveal the 
presence of any anthropogenic viruses in the chemicals or the water 
matrix. 
Each experiment included three test beakers, consisting of 1000 mL 
of secondary effluent and MS2, spiked to a final concentration of 1 x 105 
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PFU/mL The two controls and three test beakers were stirred, using the 
six-paddle jartester. After the samples were briefly stirred, and prior to 
addition of the chemicals, an aliquot was removed from each beaker, to 
determine the initial concentration of MS2. The CoMag™ process was 
then applied to the samples and after a brief settling time a final aliquot 
was removed from each beaker to determine the final MS2 titer. Refer to 
Appendix C for the CoMag™ process bench scale procedure. All 
samples were analyzed immediately and the remainders of the samples 
were archived at -80°C. 
The initial and final concentrations of all samples were established 
by creating ten-fold dilutions in phosphate buffered saline. Dilutions 
ranging from 10~2 to 10"5 were assayed to determine the initial titer. For the 
final titer, dilutions ranging from 10° to 10"3were assayed. All dilutions were 
plated in triplicate. 
A negative control consisted of 5 mL of soft agar overlay poured on 
a plate. An additional negative control, containing 5 mL of soft agar 
overlay which was previously inoculated with 200 pL of log phase E. coli, 
was also plated. A positive control consisted of 200 u l of log phase E. coli 
plated in 5 mL of a soft agar overlay. After the overlay solidified, 20 ML of 
stock MS2 was distributed onto the plate. 
All samples were analyzed using the double agar overlay method, 
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as previously described. Plates containing 30 to 300 plaques were used to 
calculate the titer of the sample. The titer of the sample was recorded as 
plaque forming units per mL (PFU/mL). 
Poliovirus type 1 and MS2 
The removal of MS2 and poliovirus type 1, using a bench scale 
model of the CoMag™ process was evaluated at room temperature 
(24°C) and then at a reduced temperature (4°C). All trials were 
performed in triplicate. One thousand milliliters of secondary effluent was 
distributed into five sterile 1200 mL beakers. Two of the beakers acted as 
controls. One of the controls consisting of secondary effluent and MS2, 
spiked to a final concentration of 1 x 105 PFU/mL, and poliovirus type 1, 
spiked to a final concentration of 1 x 105 PFU/mL. The other control 
contained 1000 mL of secondary effluent and all of the appropriate 
chemicals. This control confirmed the presence or absence of 
anthropogenic viruses. A positive control consisting of 200 u l of log phase 
E. coli plated in five mL of a soft agar overlay. After the overlay solidified, 
20 (JL of stock MS2 was distributed onto the plate. 
Additionally, three test beakers, consisting of 1000 mL of secondary 
effluent were spiked with MS2 and poliovirus type 1 to a final 
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concentration of 1 x 105 PFU/mL of each virus. The two controls and three 
test beakers were stirred using a six paddle jartester. 
After the samples were briefly stirred, and prior to chemical 
addition, an aliquot was removed from each beaker to determine the 
initial viral concentration. The CoMag™ process was applied to the 
samples and after a brief settling time a final aliquot was removed to 
determine the final titer of MS2 and poliovirus type 1 in each beaker. All 
samples were analyzed immediately and the remainder archived at -
80°C. 
The initial and final concentrations of the MS2 samples were 
determined by using ten-fold dilutions made in phosphate buffered saline. 
For the initial concentration of MS2, dilutions ranging from 10"2 to 10"5 were 
assayed and dilutions ranging from 10° to 10-3 were assayed to determine 
the final concentration of MS2. All dilutions were plated in triplicate. 
A negative control consisting of 5 mL of plated soft agar overlay. A 
second negative control contained 200 uL of log phase E. coli in 5 mL of a 
soft agar overlay. A positive control consisting of 200 u l of log phase E. 
coli in five mL of a soft agar overlay. After the overlay solidified, 20 |jL of 
stock MS2 was spotted onto the plate. 
All samples were analyzed using the double agar overlay method, 
as previously described. Plates containing 30 to 300 plaques were used to 
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calculate the titer of the sample. The titer of the sample was recorded as 
plaque forming units per mL (PFU/mL). 
The initial and final concentrations of poliovirus type 1, in all 
samples, were determined using ten-fold dilutions prepared in serum-free 
MEM. To determine the starting virus concentration, dilutions ranging from 
10"2 to 10"5 were assayed and dilutions ranging from 10° to 10"3 were 
assayed to determine the final concentration of poliovirus type 1. All 
dilutions were plated in triplicate. 
Two negative control flasks contained 100 |JL of serum-free MEM. 
Two positive control flasks contained 100 pL of 1 x 102 PFU/mL poliovirus 
type 1 stock. Only flasks containing 20 to 50 plaques were counted. 
Plaques were quantified and a PFU/mL value was determined. 
Rotavirus strain Wa and MS2 
The removal of MS2 and rotavirus strain Wa using a bench scale 
model of the CoMag™ process was evaluated at room temperature 
(24°C) and at a reduced temperature (4°C). All trials were performed in 
triplicate. One thousand milliliters of secondary effluent was placed into 
five sterile 1200 mL beakers. Two of the beakers were as controls. One of 
the controls consisting of only secondary effluent and MS2 spiked to a final 
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concentration of 1 x 105 PFU/mL and rotavirus strain Wa spiked to a final 
concentration of 1 x 105 PFU/mL. An additional control contained 1000 mL 
of secondary effluent and all of the chemicals required for the CoMag™ 
process. This control was used to demonstrate the presence or absence 
of naturally occurring virus. 
Three test beakers consisting of 1000 mL of secondary effluent and 
MS2 spiked to a final concentration of 1 x 105 PFU/mL as well as rotavirus 
strain Wa, spiked to a final concentration of 1 x 105 PFU/mL. The two 
controls and three test beakers were stirred using a six paddle jartester. 
After the samples were briefly stirred, and prior to chemical addition, an 
aliquot was removed from each beaker to determine the initial 
concentration of virus. The CoMag™ process was applied to the samples 
and after a brief settling time a final aliquot was removed to determine 
the final titer of MS2 and rotavirus strain Wa in each beaker. All samples 
were analyzed immediately and the remainder of each sample was 
archived at -80°C. 
The initial and final concentrations of MS2 samples were determined 
by using ten-fold dilutions prepared in phosphate buffered saline. Dilutions 
ranging from 10-2 to 10-5 were assayed to determine initial MS2 titer. 
Additionally, dilutions ranging from 10° to 10"3 were assayed to determine 
the final MS2 concentration. All dilutions were plated in triplicate. 
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A negative control consisted of 5 mL of plated soft agar overlay. A 
second negative control contained 200 |JL of log phase E. coli in 5 mL of 
soft agar overlay which was then plated. A positive control consisted of 
200 |JL of log phase E. coli plated in five mL of a soft agar overlay. After 
the overlay solidified, 20 (JL of stock MS2 was spotted onto the plate. 
All samples and controls were analyzed using the double agar 
overlay method as previously described. Plates containing 30 to 300 
plaques were used to calculate the titer of the sample. The titer of the 
sample was recorded as plaque forming units per mL (PFU/mL). 
The initial and final concentrations of rotavirus strain Wa, in all 
samples, were determined by using ten-fold dilutions prepared in serum-
free MEM. To determine the initial titer, dilutions ranging from 10"2 to 10"5 
were assayed. Likewise, to determine the final titer, dilutions ranging from 
10° to TO"3were analyzed. All dilutions were plated in triplicate. 
Two negative control flasks consisted of 100 ML of serum-free MEM. 
Two positive control flasks contained 100 pL of 1 x TO2 PFU/mL rotavirus 
strain Wa stock. Only flasks containing 20 to 50 plaques were counted. 
Plaques were quantified and a PFU/mL value was determined. 
Adenovirus type 2 and MS2 
The removals of MS2 and adenovirus type 2, using a bench scale 
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model of the CoMag™ process was evaluated at room temperature 
(24°C) and at a reduced temperature of (4°C). All trials were performed in 
triplicate. One thousand milliliters of secondary effluent was placed into 
five sterile 1200 mL beakers. Two of the beakers acted as controls. One of 
the controls consisted of secondary effluent and MS2, spiked to a final 
concentration of 1 x 105 PFU/mL, and adenovirus type 2, spiked to a final 
concentration of 1 x 105 TCIDso/mL. The other control contained 1000 mL 
of secondary effluent and all of the necessary chemicals. This control was 
used to demonstrate the presence or absence of any naturally occurring 
virus in the experimental matrix. 
Three test beakers, consisted of 1000 mL of secondary effluent and 
MS2, spiked at a final concentration of 1 x 105 PFU/mL as well as 
adenovirus type 2, spiked at a final concentration of 1 x 105 TCIDso/mL. 
The two controls and three test beakers were then stirred using a six 
paddle jartester. After the samples were briefly stirred, and prior to 
chemical addition, an aliquot was removed from each beaker to 
determine the initial concentration of virus. The CoMag™ process was 
then applied to the samples and, after a brief settling time, a final aliquot 
was removed to determine the final titer of MS2 and adenovirus type 2 in 
each beaker. All samples were analyzed immediately and the remainder 
of each sample was archived at -80°C. 
55 
The initial and final concentrations of the MS2 samples were 
determined by creating ten-fold dilutions using phosphate buffered saline. 
For the initial titer, dilutions ranging from 10-2 to 105 were assayed; 
additionally, dilutions ranging from 10° to 10"3 were assayed to determine 
the final MS2 concentration. All dilutions were plated in triplicate. 
A negative control consisted of 5 mL of plated soft agar overlay. A 
second negative control contained 200 pL of log phase E. coll in 5 mL of a 
soft agar overlay which was plated. A positive control consisted of 200 |JL 
of log phase E. coll plated in five mL of a soft agar overlay. After the 
overlay solidified, 20 |jL of stock MS2 was spotted onto the plate. 
All samples were analyzed using the double agar overlay method, 
as previously described. Plates containing 30 to 300 plaques were used to 
calculate the titer of the sample. The titer of the sample was recorded as 
plaque forming units per mL (PFU/mL). 
The initial and final concentrations of adenovirus type 2, in all 
samples, were determined by creating ten-fold dilutions in serum-free 
MEM. To determine the initial titer, dilutions ranging from 10-2 to 10~5 were 
assayed. Likewise, to determine the final titer, dilutions ranging from 10° to 
10"3were analyzed. All dilutions were plated in triplicate. 
Two negative control wells contained 125 JJL of serum-free MEM. 
Two positive control wells contained 125 pL of 1 x 102 TCIDso/nnL adenovirus 
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type 2 stock. Samples were assayed according to methods previously 
described. 
Adenovirus type 2 viral concentration was reported as TCID50 and 
MS2 titers are reported as PFU/mL. Due to the difference in the 
calculation of titers, a conversion from TCID50 to PFU/ mL is necessary in 
order to make a comparison possible. The mean TCID50 titer (per ml) was 
multiplied by 0.7 to predict the mean number of PFU/mL (Wijnker et al., 
2007). 
Pilot Plant Scale Experiments 
Preparation of MS2 Spike 
A high-titer stock of MS2 was cultivated and enumerated using the 
double agar overlay method, as previously described. The MS2 stock was 
then diluted in 15 L of sterile deionized water, in a 5 gallon container, 
resulting in a final dilution of 1 xlO8 PFU/mL. 
Pilot Plant at the Concord. MA Wastewater Treatment Facility 
The CoMag ™ pilot plant is located inside the Concord, MA WWTF. 
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A pilot plant flow of 100 gallons per minute (gpm) was determined to be 
consistent with the optimum flow rate established during previous 
phosphorus studies. Addition of the spiked MS2 sample occurred in the 
first rapid mix tank and was continuously metered using a positive 
displacement pump. The target concentration of MS2 was 1 x 105 PFU/mL 
Aluminum sulfate and polymer were then mixed in a series of tanks for 
coagulation and flocculation. Fine magnetite powder was also added at this 
stage to increase floe density and allow for floe removal using a magnetic 
separator. The flocculated solids settled very rapidly in the small clarifier. 
Approximately 80 percent of the solids underflow was recirculated to 
the first stage contact basin and the remaining portion was removed as waste 
sludge. The clarified effluent was passed through a magnetic separator in 
order to remove microflocs that escaped the clarifier. The detention time of 
the system was 10 minutes. Magnetite was recovered from the sludge in a 
magnetic drum separator and recycled to the magnetite feed tank for reuse. 
One hundred mL samples were drawn from the 5 gallon container used 
for spiking, as well as the tank where the MS2 was added and a port 
located distal to the magnetic separator. 
Samples were gathered at time zero and then once every 10 minutes 
for a total of three hours. The samples were stored on ice and analyzed within 
24 hours. MS2 was enumerated using the double agar overlay, as 
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previously described. Plates containing 30 to 300 plaques were used to 
calculate the titer of the sample. The final titer of the sample was 
recorded as plaque forming units per mL (PFU/mL). 
Statistical Analysis 
The log reduction value (LRV) for MS2, poliovirus type l , rotavirus 
strain Wa, and adenovirus type 2 was calculated by dividing the final viral 
concentration (Nt) by the initial viral concentration (No). These values 
were then logio transformed [logio (N/No)] and the values from the 
triplicate experiments were averaged. The value was considered 
significant at a 95% confidence level. Minitab version 15 was utilized to 
perform the statistical analysis. 
Statistical analysis of triplicate trials were performed to evaluate the 
removals of MS2 with and without magnetite, MS2 alone, MS2 and poliovirus 
type 1, MS2 and rotavirus strain Wa, and MS2 and adenovirus type 2 at 24°C 
and 4°C. The data for all four viruses were square root transformed to 
insure a normal distribution and then analyzed using a one-way ANOVA 
with Minitab v. 15. An ANOVA was performed to evaluate the following 
null hypotheses: (1) the bench scale model of the CoMag™ process does 
not have a statistically significant effect on the removal of MS2, poliovirus 
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type 1, rotavirus strain Wa, and adenovirus type 2 at 24°C or at 4°C; (2) there 
is not a statistically significant difference between the removal of MS2with 
poliovirus type 1, rotavirus strain Wa, and adenovirus type 2, compared to the 
removal of MS2 alone; (3) there is not a statistically significant difference 
between the removal of MS2 alone, MS2 with poliovirus type 1, MS2 with 
rotavirus strain Wa, and MS2 with adenovirus type 2 at 24°C, compared to 
their removal at 4°C; (4) the pilot plant scale of the CoMag™ process 
does not have a statistically significant effect on the removal of MS2; (5) 
there is no statistically significant difference between the removal of MS2, 
using the pilot plant scale CoMag™ process and the bench scale model of 
the CoMag™ process; (6) there is no statistically significant difference 
between the removals of MS2 using the bench sale model of the CoMag™ 
process when magnetite is added and when magnetite is not added. A p 
value of O.05 was chosen to determine statistical significance. 
Post hoc comparisons using the Tukey honest significant difference 
(HSD) analysis were performed. The test was performed using a P value of 
P < 0.05 to be considered statistically significant. The Tukey HSD Test was 
implemented using the means of the MS2 titers for all of the experiments 
to create a pair-wise comparison of each experiment. This test 
determined the presence of a statistically significant difference in the 




Removal of MS2 with and without Added Magnetite 
The removal of MS2, using a bench scale model of the CoMag™ 
process, with and without added magnetite, was evaluated. All trials were 
performed in triplicate. The log reduction value (LRV) for MS2 was 
calculated by dividing the final viral concentration (Nt) by the initial viral 
concentration (No). These values were then logio transformed [logio 
(N/No)], and the values from the triplicate experiments were averaged. 
The calculated values were considered statistically significant at a 95% 
confidence level. Minitab version 15 was utilized to complete the 
statistical analysis. The results of the three trials are summarized in Tables 1 
and 2 and Figures 6 and 7. 
The amount of endogenous MS2, present in the sample matrix, was 
below the detectable limit of <1 PFU/mL. The average LRV for the 
removal of MS2 using the CoMag™ process without the addition of 
magnetite, was 1.8040 with a standard deviation of 0.3280. The average 
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LRV for the removal of MS2 using the CoMag™ process with the addition 
of magnetite was 2.9638 with a standard deviation of 0.1217. Statistical 
analysis resulted in a p value of 0.005, indicating that there is a significant 
difference in the removal of MS2, when magnetite is added, versus when 
magnetite is not added. Therefore, the null hypothesis stating that 
magnetite does not have a statistically significant effect on the removal 
of MS2 was rejected. 
62 
Figure 6: The removal of MS2, using a Bench Scale model of the CoMag™ 
process, with and without added magnetite. 
A B 
Magnetite added No magnetite added 
c 
Magnetite added No magnetite added 
D 
Magnetite added No magnetite added Magnetite added No magnetite added 
One thousand milliliters of secondary effluent from the Concord, MA 
Wastewater Treatment Facility was placed into sterile 1200 mL beakers. All 
chemicals used for CoMag™ process, except for magnetite to the beaker 
on the right of each photo, were added to both beakers. Elapsed time 
after chemical addition: (A) 30 seconds (B) 1 minute (3) 30 minutes and 
(D) 1 hour. 
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S = 0.2476 R-Sq = 89.16% R-Sq(adj) = 86.45% 
Individual 95% CIs For Mean Based on 
Pooled StDev 
Level N Mean StDev 
No Magnetite 3 1.8041 0.3284 
Magnetite 3 2.9638 0.1217 
Pooled StDev = 0.2476 
— + +_ 
1.50 2.00 2.50 3.00 
Table 2: Descriptive Statistics: Mean MS2 LRV: No Magnetite vs. Magnetite 
Total Sum of 
Variable Count Mean StDev Squares Minimum Median Maximum 
No Magnetite 3 1.8040 0.3280 9.9800 1.4320 1.9260 2.0540 
Magnetite 3 2.9638 0.1217 26.3816 2.8305 2.9917 3.0691 
Data in Tables 1 and 2 represents the calculated LRV of MS2, using data 
from three separate trials. For each trail, the removal of MS2 was assayed 
in triplicate. The plaque assays were also conducted in triplicate. 
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Figure 7: Mean Log Reduction Value of MS2 Using the Bench Scale Model 































No Magnetite Magnetite 
The data represents the average LRV for MS2, detected by modified 
double agar overlay, using E. coli HS (pFamp) R as the host. Plaque assays 
were performed in triplicate and 1000 ml of secondary effluent was spiked 
with MS2 to a final concentration of 1 x 105 PFU/mL. Three trials were 
completed, each trial containing a sample size of n=3. The mean LRV of 
MS2, when magnetite was not added, was 1.8040, with a standard 
deviation of 0.3280. The mean LRV of MS2 when magnetite was added 
was 2.9638, with a standard deviation of 0.1217. A p value 0.005 (a=0.05) 
was obtained, which indicates that there is a statistically significant 
difference in the removal of MS2, from the secondary effluent samples, 
when magnetite is present versus when it is not. In Figure 7, the upper 
whisker extends to the maximum data point, for each category, and the 
lower whisker extends to the minimum data point. Each colored box 
contains the middle 50% of the data. The line, within each box, illustrates 
the median. The plus sign, within each colored box, represents the mean. 
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Removal of MS2 Using the Bench Scale Model of the CoMgq™ Process 
The removal of MS2, using a bench scale model of the CoMag™ 
process was evaluated. All trials were performed in triplicate. The LRV for 
MS2 was calculated by dividing the final viral concentration (Nt) by the 
initial viral concentration (No). These values were then logio transformed 
[logio (N/No)], and the values for each of the three experiments were 
averaged. The correlation was considered statistically significant at a 95% 
confidence level. Minitab version 15 was utilized to complete the 
statistical analysis. The results of the three trials are summarized in Tables 3 
and 4 and Figure 8. 
The amount of endogenous MS2, present in the sample matrix, was 
below the detectable limit of <1 PFU/mL The average LRV for the 
removal of MS2 was 3.0495 for trial 1, 2.9640 for trial 2, and 2.9525 for trial 3, 
respectively. Statistical analysis was performed to evaluate the following 
null hypothesis: The LRV of MS2 does not vary between trials, to a 
statistically significant degree. The statistical analysis resulted in p value of 
0.890, indicating that there is not a significant difference when comparing 
the removal of MS2 in each trial. Therefore, the null hypothesis that states 
the LRV of MS2 does not vary significantly between trials fails to be 
rejected. 
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Data in Tables 3 and 4 represents the calculated LRV of MS2, using the 
results from three separate trials. For each trail, the removal of MS2 was 
assayed in triplicate. The plaque assays were also conducted in triplicate. 
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Figure 8: Mean Log Reduction Value of MS2 for Three Trials at 24° C, Using 















The data in Figure 8 represents the average LRV for MS2, detected by 
modified double agar overlay, using E. coli HS (pFamp) R as the host. 
Plaque assays were performed in triplicate and 1000 ml of secondary 
effluent was spiked with MS2 to a final concentration of 1 x 105 PFU/mL. 
Three trials were completed, each trial containing a sample size of n=3. 
The mean LRV of MS2 for trial 1 was 3.050, with a standard deviation of 
0.276. The mean LRV of MS2 for trial 2 was 2.964, with a standard 
deviation of 0.246. The mean LRV of MS2 for trial 3 was 2.953, with a 
standard deviation of 0.015. A p value 0.890 (a=0.05) was obtained, 
which indicates that there is no statistically significant difference in the 
removal of MS2 among the three trails. Error bars corresponds to standard 
error. 
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Removal of MS2 Using the Bench Scale Model of the CoMaq™ Process at 
24°C and 4°C 
The removal of MS2, using a bench scale model of the CoMag™ 
process was evaluated at 24°C and 4°C. All trials were performed in 
triplicate. The LRV for MS2 was calculated by dividing the final viral 
concentration (Nt) by the initial viral concentration (No). These values 
were then logio transformed [logio (N/No)], and the values from the 
triplicate experiments were averaged. The correlation was considered 
statistically significant at a 95% confidence level. Minitab version 15 was 
utilized to complete the statistical analysis. 
The amount of endogenous MS2 present in the sample matrix was 
below the detectable limit of <1 PFU/mL. Statistical analysis was 
performed to evaluate the following null hypotheses: (1) The MS2 LRV 
does not significantly vary, at 24° versus 4°C, when combined with 
another virus (2) The MS2 LRV does not significantly vary, between trials at 
the same temperature (24° or 4°C), when combined with another virus. 
The LRV of MS2, at 24°C, was 2.9306 when combined with poliovirus type 
1, 2.9756 when combined with rotavirus strain Wa, and 2.8336 when 
combined with adenovirus type 2. Statistical analysis resulted in a p value 
of 0.270, indicating that there is no significant difference in the removal of 
MS2, when combined with poliovirus, rotavirus and adenovirus at 24°C. 
Therefore, the null hypothesis stating that the MS2 LRV does not 
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significantly differ at 24°C, when combined with poliovirus, rotavirus or 
adenovirus is not rejected. The results are summarized in Table 5 and 6 
and Figure 9. 
The LRV of MS2 at 4°C was 2.9885 when combined with poliovirus 
type 1, 2.8872 when combined with rotavirus strain Wa, and 2.8944 when 
combined with adenovirus type 2. Statistical analysis resulted in a p value 
of 0.476, indicating that there is not a significant difference in the removal 
of MS2, when combined with poliovirus, rotavirus or adenovirus at 4°C. 
Therefore, the null hypothesis stating that the LRV of MS2 does not 
significantly vary at 4°C, when combined with poliovirus, rotavirus or 
adenovirus, fails to be rejected. The results are summarized in Table 7 and 
8 and Figure 10. 
At 24°C, the mean LRV of MS2, when combined with poliovirus, 
rotavirus and adenovirus, was 2.9133 with a standard deviation of 0.1057. 
At 4°C, the mean LRV of MS2, when combined with poliovirus, rotavirus 
and adenovirus, was 2.9234 with a standard deviation of 0.1046. 
Statistical analysis resulted in a p value of 0.841. Therefore; the null 
hypothesis fails to be rejected, which states that the mean LRV of MS2 
does not significantly vary, at 24° versus 4°C, when combined with 
another virus. The results are summarized in Table 9 and 10 and Figure 11. 
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S = 0.09809 R-Sq = 35.38% R-Sq(adj) = 13.83% 
Level N 
MS2 24C (polio) 3 
MS2 24C (rota) 3 









Individual 95% CIs For Mean Based on 
Pooled StDev 
— + + + + — 
— + _ . + — . + — 
2.76 2.88 3.00 3.12 
Pooled StDev = 0.0981 
Table 6: Descriptive Statistics: Mean LRV of MS2 at 24°C 
Variable N 
MS2 24°C (poliovirus) 3 
MS2 24°C (rotavirus) 3 





















Data in Tables 5 and 6 represents the calculated LRV of MS2, using data 
from three separate trials. For each trail, the removal of MS2 was assayed 
in triplicate. The plaque assays were also conducted in triplicate. 
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Figure 9: Mean Log Reduction Value of MS2 at 24°C Using the Bench Scale 
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The data represents the average LRV for MS2 at 24°C, detected by 
modified double agar overlay, using E. co//-HS (pFamp) R as the host. 
Plaque assays were performed in triplicate and 1000 ml of secondary 
effluent was spiked with MS2 to a final concentration of 1 x 105 PFU/mL. 
Three trials were completed, each trial containing a sample size of n=3. 
The mean LRV of MS2, when challenged with poliovirus type 1, was 2.931 
with a standard deviation of 0.0942. The mean LRV of MS2, when 
challenged with rotavirus strain Wa, was 2.976 with a standard deviation 
of 0.1358. The mean LRV of MS2, when challenged with adenovirus type 2, 
was 2.834 with a standard deviation of 0.0395. A p value 0.270 (a=0.05) 
was obtained, which indicates that there is no statistically significant 
difference in the removal of MS2 when combined with poliovirus, rotavirus 
and adenovirus. In Figure 9, the upper whisker extends to the maximum 
data point, for each variable, and the lower whisker extends to the 
minimum data point. Each colored box contains the middle 50% of the 
data. The line within each box illustrates the median. The plus sign, within 
each colored box, represents the mean. 
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S = 0.1068 R-Sq = 21.90% R-Sq(adj) = 0.00% 
Level N 
MS2 4°C (poliovirus) 3 
MS2 4°C (rotavirus) 3 
MS2 4°C (adenovirus) 3 
Level 
MS2 4°C (poliovirus) 
MS2 4°C (rotavirus) 
MS2 4°C (adenovirus) 





Individual 95% CIs For Mean Based on 
Pooled StDev 
_+_ 
- - ) 
— + _ 
2.76 2.88 3.00 3.12 
Table 8: Descriptive Statistics: Mean LRV of MS2 4°C 
Variable N 
MS2 4°C (poliovirus) 3 
MS2 4°C (rotavirus) 3 





















Data in Tables 7 and 8 represents the calculated LRV of MS2, using data 
from three separate trials. For each trail, the removal of MS2 was assayed 
in triplicate. The plaque assays were also conducted in triplicate. 
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Figure 10: Mean Log Reduction Value of MS2 at 4°C Using the Bench Scale 
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The data represents the average LRV for MS2 at 4°C, detected by 
modified double agar overlay, using E. coli HS (pFamp) R as the host. 
Plaque assays were performed in triplicate and 1000 ml of secondary 
effluent was spiked with MS2 to a final concentration of 1 x 105 PFU/mL. 
Three trials were completed, each trial containing a sample size of n=3. 
The mean LRV of MS2, when challenged with poliovirus type 1, was 2.989 
with a standard deviation of 0.080. The mean LRV of MS2, when 
challenged with rotavirus strain Wa, was 2.887 with a standard deviation 
of 0.144. The mean LRV of MS2, when challenged with adenovirus type 2, 
was 2.894 with a standard deviation of 0.084. A p value 0.476 (a=0.05) 
was obtained, which indicates that there is no statistically significant 
difference in the removal of MS2 when combined with poliovirus, rotavirus 
and adenovirus. In Figure 10, the upper whisker extends to the maximum 
data point, for each variable, and the lower whisker extends to the 
minimum data point. Each colored box contains the middle 50% of the 
data. The line within each box illustrates the median. The plus sign, within 
each colored box, represents the mean. 
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Table 9: One-way ANOVA: Mean LRV of MS2 at 24°C and 4°C 
Source DF SS MS F P 
Factor 1 0.0005 0.0005 0.04 0.841 
Error 16 0.1769 0.0111 
Total 17 0.1774 
S = 0.1052 R-Sq = 0.26% R-Sq (adj) = 0.00% 
Individual 95% CIs For Mean Based on Pooled StDev 
Level N Mean StDev + + + + 
MS2 24°C 9 2.9133 0.1057 ( * ) 
MS2 4°C 9 2.9234 0.1046 ( * ) 
+ + + + 
2.840 2.880 2.920 2.960 
Pooled StDev = 0.1052 






















Data in Tables 9 and 10 represents the calculated LRV of MS2, using data 
from three separate trials. For each trail, the removal of MS2 was assayed 
in triplicate. The plaque assays were also conducted in triplicate. 
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Figure 11: Mean Log Reduction Value of MS2 when combined with 
Poliovirus type 1, Rotavirus strain Wa and Adenovirus type 2 at 24°C and 
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The data represents the average LRV for MS2, at 24°C and 4°C, detected 
by modified double agar overlay, using E. coli HS (pFamp) R as the host. 
Plaque assays were performed in triplicate and 1000 ml of secondary 
effluent was spiked with MS2 to a final concentration of 1 x 105 PFU/mL. 
Three trials were completed, each trial containing a sample size of n=3. 
The mean LRV of MS2, when challenged at 24°C with poliovirus type 1, 
rotavirus strain Wa, and adenovirus type 2 was 2.9133, with a standard 
deviation of 0.1057. The mean LRV of MS2, when challenged at 4°C with 
poliovirus type 1, rotavirus strain Wa, and adenovirus type 2 was 2.9234, 
with a standard deviation of 0.1046. A p value 0.841 (a=0.05) was 
obtained, which indicates that there is no statistically significant difference 
in the removal of MS2, when combined with poliovirus, rotavirus and 
adenovirus at 24° versus 4°C. In Figure 11, the upper whisker extends to 
the maximum data point, for each variable, and the lower whisker 
extends to the minimum data point. Each colored box contains the 
middle 50% of the data. The line, within each box, illustrates the median. 
The plus sign, within each colored box, represents the mean. 
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Removal of MS2, Poliovirus type 1, Rotavirus strain Wa and Adenovirus 
type 2 Using the Bench Scale Model of the CoMaa™ Process at 24°C and 
4°C 
The removals of MS2, poliovirus type 1, rotavirus strain Wa and 
adenovirus type 2, using a bench scale model of the CoMag™ process, 
were evaluated at 24°C and 4°C. All trials were performed in triplicate. 
The amount of endogenous MS2 present in the sample matrix was 
below the detectable limit of <1 PFU/mL. Statistical analysis was 
performed to evaluate the following null hypotheses: (1) there is no 
statistically significant difference between the removal of poliovirus type 1, 
rotavirus strain Wa, and adenovirus type 2 at 24°C versus 4°C (2) there is no 
statistically significant difference between the removal of MS2 with 
poliovirus type 1, MS2 with rotavirus strain Wa, and MS2 with adenovirus type 2 
at 24°C or 4°C. At 24°C, the LRV of MS2 was 2.9306 when combined with 
poliovirus type 1, 2.9756 when combined with rotavirus strain Wa, and 
2.8336 when combined with adenovirus type 2. At 4°C, The LRV of MS2 
was 2.9885 when combined with poliovirus type 1, 2.8872 when combined 
with rotavirus strain Wa, and 2.8944 when combined with adenovirus type 
2. The LRV of poliovirus was 3.5545 with a standard deviation of 0.0975, 
at 24°C, and 3.2440 with a standard deviation of 0.1223, at 4°C. The results 
are summarized in Tables 11 through 28 and Figures 12 through 20. 
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The LRV of rotavirus was 3.5482 with a standard deviation of 0.1504, 
at 24°C, and 3.5114 with a standard deviation of 0.1161, at 4°C. The results 
are summarized in Tables 21 through 24 and Figures 17 and 18. The LRV of 
adenovirus was 3.3.493, at 24°C, with a standard deviation of 0.1740 and 
3.470 with a standard deviation of 0.2330, at 4°C. The results are 
summarized in Tables 25 through 284 and Figures 19 and 20. 
The statistical analysis evaluating the removal of MS2 in comparison 
with poliovirus, rotavirus and adenovirus, at 24°C, resulted in p values of 
0.001, 0.008, and 0.003 respectively. These p values indicate that there is a 
significant difference in the removal of MS2 as well as poliovirus, rotavirus, 
and adenovirus at 24°C. The statistical analysis evaluating the removal of 
MS2, in comparison with poliovirus, rotavirus and adenovirus at 4°C, 
resulted in p values of 0.039, 0.004, and 0.016 respectively. These p values 
imply that there is a significant difference in the removal of MS2 and the 
removal of poliovirus, rotavirus and adenovirus at 4°C. Therefore, the null 
hypothesis stating that there is no statistically significant difference in the 
removal of MS2 with poliovirus type 1, MS2 with rotavirus strain Wa, and MS2 
with adenovirus type 2 at 24°C or 4°C is rejected. 
The mean LRV of poliovirus, at 24°C, was 3.5545 with a standard 
deviation of 0.0975. At 4°C, the mean LRV was 3.2440 with a standard 
deviation of 0.1223. Statistical analysis resulted in a p value of 0.026; 
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therefore, the null hypothesis stating that poliovirus LRV does not 
statistically vary, at 24° versus 4°C, is rejected. The mean LRV of rotavirus, 
at 24°C, was 3.5482 with a standard deviation of 0.1504. At 4°C, the mean 
LRV was 3.5144 with a standard deviation of 0.1161. Statistical analysis 
resulted in a p value of 0.774; therefore, the null hypothesis stating that 
poliovirus LRV does not statistically vary, at 24° versus 4°C, fails to be 
rejected. The mean LRV of adenovirus, at 24°C, was 3.493 with a standard 
deviation of 0.1740. At 4°C, the mean LRV was 3.3.470 with a standard 
deviation of 0.2330. Statistical analysis resulted in a p value of 0.896 
therefore; the null hypothesis stating that poliovirus LRV does not 
statistically vary at 24° versus 4°C fails to be rejected. 
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Table 11: One-way ANOVA: Mean LRV of Poliovirus at 24°C versus 
Poliovirus at 4°C 
Source DF SS MS F P 
Factor 1 0.1446 0.1446 11.82 0.026 
Error 4 0.0490 0.0122 
Total 5 0.1936 
S = 0.1106 R-Sq = 74.71% R-Sq(adj) = 68.39% 
Individual 95% CIs For Mean Based on 
Pooled StDev 
Level N Mean StDev + + + + -
Poliovirus 24°C 3 3.5545 0.0975 ( * ) 
Poliovirus 4°C 3 3.2440 0.1223 ( * ) 
+ + + +._ 
3.20 3.40 3.60 3.80 
Pooled StDev = 0.1106 
Table 12: Descriptive Statistics: Mean LRV of Poliovirus at 24°C versus 






















Data in Tables 11 and 12 represents the calculated LRV for poliovirus type 
1, using data from three separate trials obtained when performing a 
bench scale model of the CoMag™ process. For each trail, the removal 
of poliovirus was assayed in triplicate. The plaque assays were also 
conducted in triplicate. 
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Figure 12: Mean Log Reduction Value of Poliovirus type la t 24°C versus 
the Mean Log Reduction Value of Poliovirus type 1 at 4°C, Using the Bench 
















j _____ j 
Poliovirus 24°C Poliovirus 4°C 
The data represents the average LRV for poliovirus type 1, at 24°C versus 
4°C, using a bench scale model of the CoMdg™ process. Poliovirus type 
1 was detected using a modified neutral red plaque-forming unit (PFU) 
method, in BGMK cells. Plaque assays were performed in triplicate and 
1000 ml of secondary effluent was spiked with poliovirus to a final 
concentration of 1 x 105 PFU/mL. Three trials were completed; each trial 
containing a sample size of n=3. The mean LRV of poliovirus, at 24°C, was 
3.5545 with a standard deviation of 0.0975. The mean LRV of poliovirus, at 
4°C, was 3.2440 with a standard deviation of 0.1223. A p value 0.026 
(a=0.05) was obtained, which indicates that there is a statistically 
significant difference in the removal of poliovirus, at 24°C versus 4°C. In 
Figure 12, the upper whisker extends to the maximum data point, for each 
variable, and the lower whisker extends to the minimum data point. Each 
colored box contains the middle 50% of the data. Each line within the box 
illustrates the median. The plus sign, within each colored box, represents 
the mean. 
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Table 13: One-way ANOVA: Mean LRV of Rotavirus at 24°C versus 
Rotavirus at 4°C 
Source DF SS MS F P 
Factor 1 0.0017 0.0017 0.09 0.774 
Error 4 0.0722 0.0181 
Total 5 0.0739 
S = 0.1344 R-Sq = 2.31% R-Sq(adj) = 0.00% 
Individual 95% CIs For Mean Based on 
Pooled StDev 
Level N Mean StDev — + + + + — 
Rotavirus 24°C 3 3.5482 0.1504 ( * ) 
Rotavirus 4°C 3 3.5144 0.1161 ( * ) 
— + + + + — 
3.36 3.48 3.60 3.72 
Pooled StDev = 0.1344 
Table 14: Descriptive Statistics: Mean LRV of Rotavirus at 24°C versus 
Rotavirus at 4°C 
Variable N Mean StDev Minimum Median Maximum 
Rotavirus 24°C 3 3.5482 0.1504 3.3881 3.5698 3.6866 
Rotavirus 4°C 3 3.5144 0.1161 3.3819 3.5631 3.5983 
Data in Tables 13 and 14 represents the calculated LRV for rotavirus strain 
Wa. Data were utilized that resulted from performing three separate trials, 
using a bench scale model of the CoMag™ process. For each trail, the 
removal rotavirus was assayed in triplicate. The plaque assays were also 
conducted in triplicate. 
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Figure 13: Mean Log Reduction Value of Rotavirus strain Wa at 24°C versus 
Mean Log Reduction Value of Rotavirus strain Wa at 4°, Using the Bench 




















Rotavirus 24°C Rotavirus 4°C 
The data represents the average LRV for rotavirus strain Wa at, 24°C versus 
4°C, using a bench scale model of the CoMag™ process. Rotavirus strain 
Wa was detected using a modified crystal violet plaque-forming unit (PFU) 
method, with Ma-104 cells acting as the host. Plaque assays were 
performed in triplicate and 1000 ml of secondary effluent was spiked with 
rotavirus to a final concentration of 1 x 105 PFU/mL. Three trials were 
completed, each trial containing a sample size of n=3. At 24°C, the mean 
LRV of rotavirus was 3.5482 with a standard deviation of 0.1504. At 4°C, 
the mean LRV of rotavirus was 3.5144 with a standard deviation of 0.1161. 
A p value of 0.7740 (a=0.05) was obtained, which indicates that there is 
not a statistically significant difference in the removal of rotavirus at 24°C 
versus 4°C. In Figure 13, the upper whisker extends to the maximum data 
point, for each variable, and the lower whisker extends to the minimum 
data point. Each colored box contains the middle 50% of the data. The 
line within each box illustrates the median. The plus sign, within each 
colored box, represents the mean. 
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Table 15: One-way ANOVA: Mean LRV of Adenovirus at 24°C versus 4°C 
Source DF SS MS F P 
Factor 1 0.0008 0.0008 0.02 0.896 
Error 4 0.1691 0.0423 
Total 5 0.1699 
S = 0.2056 R-Sq = 0.48% R-Sq(adj) =0.00% 
Individual 95% CIs For Mean Based on 
Pooled StDev 
Level N Mean StDev —+ + + + 
Adenovirus 24°C 3 3.4933 0.1739 ( * ) 
Adenovirus 4°C 3 3.4700 0.2330 ( * ) 
—+ + + + 
3.20 3.40 3.60 3.80 
Pooled StDev = 0.2056 






















Data in Tables 15 and 16 represents the calculated LRV of adenovirus type 
2, using data from gathered from three separate trials employing a bench 
scale model of the CoMag™ process. For each trail, the removal 
adenovirus was assayed in triplicate. The plaque assays were also 
conducted in triplicate. 
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Figure 14: Mean Log Reduction Value of Adenovirus type 2 at 24°C versus 
the Mean Log Reduction Value of Adenovirus type 2 at 4°C, Using the 



















Adenovirus 24°C Adenovirus 4°C 
The data represents the average LRV for adenovirus type 2 at, 24°C versus 
4°C, using a bench scale model of the CoMag™ process. Adenovirus 
type 2 was detected using the Reed and Muench TCID50 method, with 
A549 cells as the host. Plaque assays were performed in triplicate and 
1000 ml of secondary effluent was spiked with adenovirus to a final 
concentration of 1 x 105 TCID50/ mL. Three trials were completed, each 
trial containing a sample size of n=3. The mean LRV of adenovirus, at 
24°C, was 3.4933 with a standard deviation of 0.1740. The mean LRV of 
rotavirus, at 4°C, was 3.4700 with a standard deviation of 0.2330. A p 
value 0.8960 (a=0.05) was obtained, which indicates that there is no 
statistically significant difference in the removal of adenovirus at 24°C 
versus 4°C. In Figure 14, the upper whisker extends to the maximum data 
point, for each variable, and the lower whisker extends to the minimum 
data point. Each colored box contains the middle 50% of the data. The 
line within each box illustrates the median. The plus sign, within each 
colored box, represents the mean. 
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S = 0.09588 R-Sq = 94.07% R-Sq(adj) = 92.59% 
Level N 
MS2 24°C 3 








Individual 95% CIs For Mean Based on 
Pooled StDev 
+ + + + 
- ) 
_+ +_ .+— -+ 
3.00 3.25 3.50 3.75 
Table 18: Descriptive Statistics: Mean LRV of MS2 at 24°C and Poliovirus 
24°C 
Variable N Mean StDev Minimum Median Maximum 
MS2 24°C 3 2.9306 0.0942 2.8221 2.9794 2.9905 
Poliovirus 24°C 3 3.5545 0.0975 3.4735 3.5272 3.6628 
Data in Tables 17 and 18 represents the calculated LRV of MS2 and 
poliovirus type 1, at 24°C, using data from three separate trials, obtained 
by performing a bench scale model of the CoMag™ process. For each 
trail, the removal MS2 and poliovirus was assayed in triplicate. The plaque 
assays were also conducted in triplicate. 
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Figure 15: Mean Log Reduction Value of MS2 versus the Mean Log 
Reduction Value of Poliovirus type 1 at 24°C, Using the Bench Scale Model 
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MS2 24°C (poliovirus) Poliovirus 24°C 
The data represents the average LRV of MS2 and poliovirus type 1, at 
24°C, using a bench scale model of the CoMag™ process. MS2 and 
poliovirus were spiked into the same test sample. Three trials were 
completed, each trial containing a sample size of n=3. The mean LRV of 
MS2 was 2.9306 with a standard deviation of 0.10942. The mean LRV of 
poliovirus was 3.5545 with a standard deviation of 0.0975. A p value 
0.0010 (a=0.05) was obtained, which indicates that there is a statistically 
significant difference in the removal of MS2 at 24°C and poliovirus at 24°C. 
In Figure 15, the upper whisker extends to the maximum data point, for 
each variable, and the lower whisker extends to the minimum data point. 
Each colored box contains the middle 50% of the data. The line within 
each box illustrates the median. The plus sign, within each colored box, 
represents the mean. 
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0.0979 9.17 0.039 
0.0107 
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2.85 
= 0.1033 
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( * ) 
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3.00 3.15 3.30 





N Mean StDev Minimum Median Maximum 
3 2.9885 0.0800 2.9055 2.9950 3.0650 
3 3.2440 0.1223 3.1034 3.3022 3.3263 
Data in Tables 19 and 20 represents the calculated LRV of MS2 and 
poliovirus type 1, at 4°C, using data from three separate trials obtained by 
performing a bench scale model of the CoMag™ process.' For each trail, 
the removal MS2 and poliovirus was assayed in triplicate. The plaque 
assays were also conducted in triplicate. 
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Figure 16: Mean Log Reduction Value of MS2 versus the Mean Log 
Reduction Value of Poliovirus type 1 at 4°C, Using the Bench Scale Model of 
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MS2 4°C (poliovirus) Poliovirus 4°C 
The data represents the average LRV of MS2 and poliovirus type 1, at 4°C, 
using a bench scale model of the CoMag™ process. One thousand 
milliliters of secondary effluent was spiked with MS2 and poliovirus for a 
target concentration of 1 x 105 PFU/mL and plaque assays were 
performed. Three trials were completed, each trial containing a sample 
size of n=3. The mean LRV of MS2 was 2.9885 with a standard deviation of 
0.0800. The mean LRV of poliovirus was 3.2440 with a standard deviation 
of 0.1223. A p value 0.0390 (a=0.05) was obtained, which indicates that 
there is a statistically significant difference in the removal of MS2 at 4°C 
and poliovirus at 4°C. In Figure 16, the upper whisker extends to the 
maximum data point, for each variable, and the lower whisker extends to 
the minimum data point. Each colored box contains the middle 50% of 
the data. The line within each box illustrates the median. The plus sign, 
within each colored box, represents the mean. 
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Table 21: One-way ANOVA: Mean LRV of MS2 at 24°C and Rotavirus at 
24°C 
Source DF SS MS F P 
Factor 1 0.4917 0.4917 23.95 0.008 
Error 4 0.0821 0.0205 
Total 5 0.5739 
S = 0.1433 R-Sq = 85.69% R-Sq(adj) = 82.11% 
Level N Mean StDev 
MS2 24°C 3 2.9756 0.1358 
Rotavirus 24°C 3 3.5482 0.1504 
Individual 95% CIs For Mean Based on 
Pooled StDev 
Level + + + +-
MS2 24°C (rotavirus) ( * ) 
Rotavirus 24°C ( * 1 
+ +_ 
3.00 3.30 3.60 3.90 
Pooled StDev = 0.1433 























Data in Tables 21 and 22 represents the calculated LRV of MS2 and 
rotavirus strain Wa, at 24°C, using data obtained from three separate trials 
utilizing a bench scale model of the CoMag™ process. For each trail, the 
removal MS2 and rotavirus was assayed in triplicate. The plaque assays 
were also conducted in triplicate. 
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Figure 17: Mean Log Reduction Value of MS2 versus the Mean Log 
Reduction Value of Rotavirus strain Wa at 24°C, Using the Bench Scale 


















MS2 24°C (rotavirus) Rotavirus 24°C 
The data represents the average LRV of MS2 and rotavirus strain Wa, at 
24°C, using a bench scale model of the CoMag™ process. One thousand 
milliliters of secondary effluent was spiked with MS2 and rotavirus for a 
target concentration of 1 x 105 PFU/mL and plaque assays were 
performed. Three trials were completed; each trial containing a sample 
size of n=3. The mean LRV of MS2 was 2.9756 with a standard deviation of 
0.1358. The mean LRV of rotavirus was 3.5482 with a standard deviation of 
0.1504. A p value of 0.0080 (a=0.05) was obtained, which indicates that 
there is a statistically significant difference in the removal of MS2 at 24°C 
and rotavirus at 24°C. In Figure 17, the upper whisker extends to the 
maximum data point, for each variable, and the lower whisker extends to 
the minimum data point. Each colored box contains the middle 50% of 
the data. The line within each box illustrates the median. The plus sign, 
within each colored box, represents the mean. 
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Table 23: One-way ANOVA: Mean LRV of MS2 at 4°C and Rotavirus at 4°C 
Source DF SS MS F P 
Factor 1 0.5902 0.5902 34.49 0.004 
Error 4 0.0685 0.0171 
Total 5 0.6586 
S = 0.1308 R-Sq = 89.61% R-Sq(adj) = 87.01% 
Level N Mean StDev 
MS2 4°C 3 2.8872 0.1440 
Rotavirus 4°C 3 3.5144 0.1161 
Individual 95% CIs For Mean Based on 
Pooled StDev 
Level -+ + + + 
MS2 4°C (rotavirus) ( * ) 
Rotavirus 4°C ( * ) 
.+ + + + 
2.70 3.00 3.30 3.60 
Pooled StDev = 0.1308 
Table 24: Descriptive Statistics: Mean LRV of MS2 at 4°C and Rotavirus at 
4°C 
Variable N Mean StDev Minimum Median Maximum 
MS2 4°C 3 2.8872 0.1440 2.7362 2.9023 3.0231 
Rotavirus 4°C 3 3.5144 0.1161 3.3819 3.5631 3.5983 
Data in Tables 23 and 24 represents the calculated LRV of MS2 and 
rotavirus strain Wa, at 4°C, utilizing data obtained from three separate 
trials utilizing a bench scale model of the CoMag™ process. For each 
trail, the removal MS2 and rotavirus was assayed in triplicate. The plaque 
assays were also conducted in triplicate. 
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Figure 18: Mean Log Reduction Value of MS2 versus the Mean Log 
Reduction Value of Rotavirus strain Wa at 4° Using the Bench Scale Model 
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MS2 4°C (rotavirus) Rotavirus 4°C 
The data represents the average LRV of MS2 and rotavirus strain Wa, at 
4°C, using a bench scale model of the CoMag™ process. One thousand 
milliliters of secondary effluent was spiked with MS2 and rotavirus for a 
target concentration of 1 x 105 PFU/mL and plaque assays were 
performed. Three trials were completed, each trial containing a sample 
size of n=3. The mean LRV of MS2 was 2.8872 with a standard deviation of 
0.1440. The mean LRV of rotavirus was 3.5144 with a standard deviation of 
0.1161. A p value of 0.0040 (a=0.05) was obtained, which indicates that 
there is a statistically significant difference in the removal of MS2 at 4°C 
and rotavirus at 4°C. In Figure 18, the upper whisker extends to the 
maximum data point, for each variable, and the lower whisker extends to 
the minimum data point. Each colored box contains the middle 50% of 
the data. The line within each box illustrates the median. The plus sign, 
within each colored box, represents the mean. 
93 






























N Mean StDev 
3 2.8336 0.0395 
3 3.4933 0.1739 
Individual 95% CIs For Mean Based on 
Pooled StDev 
..+ + + + 
( - - * ) 
(-—* ) 
..+ + + + 
2.70 3.00 3.30 3.60 
Pooled StDev = 0.1261 























Data in Tables 25 and 26 represents the calculated LRV of MS2 and 
adenovirus type 2, at 24°C, using data from three separate trials that 
utilized a bench scale model of the CoMag™ process. For each trail, the 
removal MS2 and adenovirus was assayed in triplicate. The plaque assays 
were also conducted in triplicate. 
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Figure 19: Mean Log Reduction Value of MS2 versus the Mean Log 
Reduction Value of Adenovirus type 2 at 24°C, Using the Bench Scale 




















MS2 24°C (adenovirus) Adenovirus 24°C 
The data represents the average LRV of MS2 and adenovirus type 2, at 
24°C, using a bench scale model of the CoMag™ process. One thousand 
milliliters of secondary effluent was spiked with MS2 and adenovirus for a 
target concentration of 1 x 105 PFU/mL and plaque assays were 
performed. Three trials were completed; each trial containing a sample 
size of n=3. The mean LRV of MS2 was 2.8336 with a standard deviation of 
0.0395. The mean LRV of adenovirus was 3.4930 with a standard deviation 
of 0.1740. A p value of 0.0030 (a=0.05) was obtained, which indicates 
that there is a statistically significant difference in the removal of MS2 at 
24°C and adenovirus at 24°C. In Figure 19, the upper whisker extends to 
the maximum data point, for each variable, and the lower whisker 
extends to the minimum data point. Each colored box contains the 
middle 50% of the data. The line within each box illustrates the median. 
The plus sign, within each colored box, represents the mean. 
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Data in Tables 27 and 28 represents the calculated LRV of MS2 and 
adenovirus type 2 at 4°C, using data from three separate trials, which 
utilized a bench scale model of the CoMag™ process. For each trail, the 
removal MS2 and adenovirus was assayed in triplicate. The plaque assays 
were also conducted in triplicate. 
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Figure 20; Mean Log Reduction Value of MS2 versus the Mean Log 
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MS2 4°C (adenovirus) Adenovirus 4°C 
The data represents the average LRV of MS2 and adenovirus type 2, at 
4°C, using a bench scale model of the CoMag™ process. One thousand 
milliliters of secondary effluent was spiked with MS2 and adenovirus for a 
target concentration of 1 x 105 PFU/mL and plaque assays were 
performed. Three trials were completed; each trial containing a sample 
size of n=3. The mean LRV of MS2 was 2.8944 with a standard deviation of 
0.0841. The mean LRV of adenovirus was 3.4700 with a standard deviation 
of 0.2330. A p value of 0.0160 (a=0.05) was obtained, which indicates 
that there is a statistically significant difference in the removal of MS2 at 
4°C and adenovirus at 4°C. In Figure 20, the upper whisker extends to the 
maximum data point, for each variable, and the lower whisker extends to 
the minimum data point. Each colored box contains the middle 50% of 
the data. The line within each box illustrates the median. The plus sign, 
within each colored box, represents the mean. 
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Removal of MS2 Using the Bench Scale Model of the CoMag™ versus the 
Removal of MS2 using the CoMaa™ Pilot Plant 
The removal of MS2 using a bench scale model of the CoMag™ 
process was compared to the removal of MS2 utilizing the 100 gpm 
CoMag™ pilot plant. All trials were performed in triplicate. For the pilot 
plant challenge, MS2 was spiked into 15L of sterile water, yielding a final 
concentration of 3.37 x 106 PFU/mL. The CoMag™ process was then 
applied. 
The amount of endogenous MS2, present in the sample matrix, was 
below the detectable limit of <1 PFU/mL. An average 62 PFU/ mL was 
detected in the influent of the CoMag™ pilot plant, which was later 
normalized in the calculations. Statistical analysis was performed to 
evaluate the following null hypotheses: (1) the pilot plant scale of the 
CoMag™ process does not have a statistically significant effect on the 
removal of MS2 between trails (2) there is no statistically significant 
difference between the removal of MS2, using the pilot plant scale 
CoMag™ process versus the bench scale model of the CoMag™ process. 
The average LRV for the removal of MS2, using the bench scale 
model, was 2.913 at 24°C. The average LRV for the removal of MS2 using 
the Bench scale model, at 4°C, was 2.9234. The average LRV for the 
removal of MS2, using the pilot plant, was 2.0967. The statistical analysis 
resulted in a p value of 0.000, at both 24°C and 4°C , indicating that there 
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is a significant difference in the removal of MS2, using the bench scale 
model versus the pilot plant. Therefore, the null hypothesis stating there is 
no statistically significant difference in the removal of MS2, using the pilot 
plant scale CoMag™ process versus the bench scale model of the CoMag™ 
process is rejected. The results are summarized in Tables 31 through 34 and 
Figures 22 and 23. 
Regarding the CoMag™ pilot plant, the mean LRV for MS2 was 
2.1076 for trial 1, 2.0765 for trial 2, and 2.1064 for trial 3, respectively. The 
results are summarized in Tables 29 and 30 and Figures 21. A p value 0..786 
(a=0.05) was obtained, which indicates that there is no statistically 
significant difference in the removal of MS2, between trails, when using 
the CoMag™ pilot plant. Therefore, the null hypothesis stating that the 
pilot plant scale of the CoMag™ process does not have a statistically 
significant effect on the removal of MS2, between trails, fails to be 
rejected. A Tukey family error rate was conducted to analyze any 
significant pairwise differences between level means. From this analysis, it 
was concluded that no statistically significant pairwise interactions exist 
among the means. 
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Table 29: Two-way ANOVA: Pilot Plant Mean LRV versus Trial and Test 
Source DF 
MS2 lest 2 
MS2 replicate 1 
Error 2 
Total 5 
SS MS F P 
0.011234 0.0056172 0.27 0.786 
0.097283 0.0972827 4.71 0.162 
0.041330 0.0206652 
0.149847 










Individual 95% CIs For Mean Based on Pooled StDev 
.+ +_ 
* 
2.75 3.00 3.25 
— + 
3.50 
Individual 95% CIs For Mean Based on Pooled StDev 
+ + + + 
( * ) 
-+-
2.50 2.75 3.00 
. . .+— 
3.25 
Table 30: Tukey 95% Simultaneous Confidence Intervals: All Pairwise 
Comparisons of Pilot Plant Mean LRV 
Individual confidence level = 97.94% 
Run 1 subtracted from: 
Lower 
Run 2 -0.2992 





-0.30 -0.15 0.00 0.15 
Run 2 subtracted from: 
Run 3 
Lower Center Upper 
-0.2382 0.0299 0.2980 
_+ +_ 
-+- —+_ 
-0.30 -0.15 0.00 0.15 
The data in Tables 29 and 30 represents the calculated LRV of MS2, using 
data from three separate trials which employed a pilot plant model of the 
CoMag™ process. In each trail, the removal of MS2 was assayed in 
triplicate. The plaque assays were also conducted in triplicate. 
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Run 1 Run 2 Run 3 
The data represents the average LRV for MS2, using the pilot scale 
CoMag™ process. MS2 was detected by modified double agar overlay, 
using E. coli HS (pFamp) R as the host. Plaque assays were performed in 
triplicate and 1000 ml of secondary effluent was spiked with MS2 to a final 
concentration of 1 x 105 PFU/mL. Three trials were completed, each trial 
containing a sample size of n=3. The mean LRV was 2.1076 for trial 1, 
2.0765 for trial 2, and 2.1064 for trial 3. A p value of 0.941 (a=0.05) was 
obtained, which indicates that there is not a statistically significant 
difference in the removal of MS2, between trails, when using the CoMag™ 
pilot plant. In Figure 21, the upper whisker extends to the maximum data 
point, for each variable, and the lower whisker extends to the minimum 
data point. Each colored box contains the middle 50% of the data. The 
line within each box illustrates the median. The plus sign, within each 
colored box, represents the mean. 
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Table 31: One-way ANOVA: MS2 Bench Scale Mean LRV at 24°C and Pilot 
Plant Mean LRV 
Source DF SS 
Factor 3 3.7828 
Error 20 0.3651 






S = 0.1351 R-Sq = 91.20% R-Sq(adj) = 89.88% 
Level 
MS2 24°C (poliovirus) 
MS2 24°C (rotavirus) 
MS2 24°C (adenovirus) 
LRV 
Level 
MS2 24°C (poliovirus) 
MS2 24°C (rotavirus) 
MS2 24°C (adenovirus) 











Individual 95% CIs For Mean Based on 
Pooled StDev 
— + — 
K-) 
—+ + + 
( - - * - - ) 
(—* - " ) 
( - - * ) 
Pooled StDev = 0.1351 
—+ + + +— 
2.10 2.40 2.70 3.00 
Table 32: Descriptive Statistics: MS2 Mean LRV at 24°C and Pilot Plant 
Mean LRV 
Variable 
MS2 24°C (poliovirus) 
MS2 24°C (rotavirus) 
MS2 24°C (adenovirus) 































Data in Tables 31 and 32 represents the calculated LRV of MS2, utilizing 
data from three separate trials comparing a bench scale model and a 
pilot plant model of the CoMag™ process. For each trail, the removal of 
MS2 was assayed in triplicate. The plaque assays were also conducted in 
triplicate. 
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Figure 22: Mean Log Reduction Value of MS2 at 24°C, Using the Bench 
Scale Model of the CoMag™ Process, versus the Mean Log Reduction 
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MS2 24°C (poliovirus) MS2 24°C (rotavirus) MS2 24°C (adenovirus) Pilot Plant LRV 
The data represents the average LRV for MS2, at 24°C, using a bench 
scale model of the CoMag™ process versus the pilot scale CoMag™ 
process. MS2 was detected by modified double agar overlay, using E. 
coli HS (pFamp) R as the host. Plaque assays were performed in triplicate 
and 1000 ml of secondary effluent was spiked with MS2 to a final 
concentration of 1 x 105 PFU/mL. Three trials were completed, each trial 
containing a sample size of n=3. When challenged with poliovirus type 1, 
the mean LRV of MS2, was 2.931, with a standard deviation of 0.0942. The 
mean LRV of MS2, when challenged with rotavirus strain Wa, was 2.9756 
with a standard deviation of 0.136. The mean LRV of MS2, when 
challenged with adenovirus type 2, was 2.8336 with a standard deviation 
of 0.0395. When challenged at the CoMag™ pilot plant, the mean LRV of 
MS2 was 2.097 with a standard deviation of 0.148. A p value of 0.000 
(a=0.05) was obtained, which indicates that there is a statistically 
significant difference in the removal of MS2, using the bench scale model 
versus the pilot plant trial. In Figure 22, the upper whisker extends to the 
maximum data point, for each variable, and the lower whisker extends to 
the minimum data point. Each colored box contains the middle 50% of 
the data. The line within each box illustrates the median. The plus sign, 
within each colored box, represents the mean. 
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S = 0.1371 R-Sq = 91.14% R-Sq(adj) = 89.81% 
Level N 
MS2 4°C (poliovirus) 3 
MS2 4°C (rotavirus) 3 
MS2 4°C (adenovirus) 3 
Pilot Plant LRV 15 
Level 
MS2 4°C (poliovirus) 
MS2 4°C (rotavirus) 
MS2 4°C (adenovirus) 
Pilot Plant LRV 











Individual 95% CIs For Mean Based on 
Pooled StDev 
+ - ~+ 
(-*-) 
-+~ — + 
+— — + 
( - - * - - ) 
( - -* - - - ) 
( - -* - - - ) 
. . + — + — 
2.10 2.40 2.70 3.00 
Table 34: Descriptive Statistics: MS2 Bench Scale Mean LRV at 4°C and 
Pilot Plant LRV 
Variable 
MS2 4°C (poliovirus) 
MS2 4°C (rotavirus) 
MS2 4°C (adenovirus) 































Data in Tables 33 and 34 represents the calculated LRV of MS2, utilizing 
data from three separate trials, comparing a bench scale model and a 
pilot plant model of the CoMag™ process. For each trail, the removal of 
MS2 was assayed in triplicate. The plaque assays were also conducted in 
triplicate. 
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Figure 23: Mean Log Reduction Value of MS2 at 4°C, Using the Bench Scale 
Model of the CoMag™ Process versus, the Mean Log Reduction of the 
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Pilot Plant LRV 
The data represents the average LRV for MS2, at 4°C, using a bench scale 
model of the CoMag™ process versus the pilot- scale CoMag™ process. 
MS2 was detected by modified double agar overlay, using £. coli HS 
(pFamp) R as the host. Plaque assays were performed in triplicate and 
1000 ml of secondary effluent was spiked with MS2 to a final 
concentration of 1 x 105 PFU/mL. Three trials were completed, each trial 
containing a sample size of n=3. The mean LRV of MS2, when challenged 
with poliovirus type 1, was 2.989 with a standard deviation of 0.080. The 
mean LRV of MS2, when challenged with rotavirus strain Wa, was 2.887 
with a standard deviation of 0.144. The mean LRV of MS2, when 
challenged with adenovirus type 2, was 2.894 with a standard deviation of 
0.084. The mean LRV of MS2, when challenged at the CoMag™ pilot 
plant, was 2.097 with a standard deviation of 0.148. A p value of 0.000 
(a=0.05) was obtained, which indicates that there is a statistically 
significant difference in the removal of MS2 using the bench scale model 
versus the pilot plant process. In Figure 23, the upper whisker extends to 
the maximum data point, for each variable, and the lower whisker 
extends to the minimum data point. Each colored box contains the 
middle 50% of the data. The line within each box illustrates the median. 




An increasing number of municipal wastewater treatment facilities 
in the United States are now required to perform tertiary treatment of 
wastewater. The move beyond primary and secondary treatment is being 
implemented to achieve the more stringent parameters enforced by the 
Environmental Protection Agency for the removal of containments such 
as nutrients, toxic compounds and suspended solids. One such 
contaminant is phosphorus which is normally in short supply in freshwater 
systems, however it is abundant in primary and secondary effluent, 
because fecal waste contains high levels of phosphorous. If the 
phosphorus content of the water released by a treatment plant is not 
limited algal blooms may develop resulting in eutrophication which may 
lead to deaths of ponds, lakes and rivers. 
The supply of phosphorus varies depending on the location of the 
watershed, human activities and nonpoint sources. The phosphorus 
loading from nonpoint sources, such as agriculture runoff is minimal in the 
summer due to a smaller number of rain events. The discharge of treated 
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wastewater can be the most significant contributor to the phosphorus 
levels in freshwater during the summer months. To deal with this issue, the 
Environmental Protection Agency is requiring some wastewater treatment 
facilities to reduce their phosphorus discharge during the summer months. 
In 2006, the Concord MA Wastewater Treatment Facility's (WWTF) National 
Pollutant Discharge Elimination System (NPDES) permit required the 
phosphorus level of their effluent to be reduced from 0.75 to 0.20 mg/L 
(EPA, 2006b). With existing alum addition to secondary effluent, the 
Concord WWTF was only able to reduce the phosphorus level to between 
0.6 and 0.7 mg/L. An alternate form of tertiary treatment with a small 
footprint and low operation and maintenance costs was necessary to 
achieve the 0.2 mg/L phosphorus goal. The Concord WWTF is currently 
assessing the feasibility of the CoMag™ process to achieve phosphorus 
levels required by the new NPDES permit because the process has proved 
particularly effective at removing phosphorus at several other wastewater 
treatment facilities (Cambridge Water Technology. 2007). 
The CoMag™ process is capable of effectively removing a variety 
of substances from water via high gradient magnetic separation (HGMS). 
All particles are classified as ferromagnetic, paramagnetic, or 
diamagnetic, based on their magnetic susceptibility. The magnetic 
susceptibility of a material determines its recovery from water or removal 
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as a waste product. The CoMag™ process separates weakly magnetic 
and non-magnetic particles facilitated by the addition of particles that 
possess a high magnetic susceptibility to form aggregates of diamagnetic 
particles. Viruses are diamagnetic particles, and they may therefore be 
removed from water using HGMS. A favorable aspect of the CoMag™ 
process is the potential for pathogen removal, especially viruses. While 
the original intention of the CoMag™ process was phosphorus removal, 
this study examined the possible use of the process for the removal of 
viruses in a bench model and at the pilot plant. 
The isoelectric point of magnetite is 7.5 ± 0.5. Therefore, under 
acidic conditions, the surface of magnetite displays a net positive charge, 
which attracts negatively charged material. When the pH is elevated to 
alkaline conditions, the surface of magnetite becomes negatively 
charged and any previously attached negatively charged material is 
repelled. Thus, as a result of the inherent magnetic properties of 
magnetite at an acidic pH, it functions as an adsorbent for negatively 
charged colloids, organic materials, bacteria and viruses (Anderson et al., 
1982). MS2, poliovirus, rotavirus, and adenovirus behave as charged 
colloids in an ionic environment because of their small size. If the 
isoelectric point of a virus differs from the isoelectric point of magnetite 
the pH may be adjusted to facilitate electrostatic binding of viral particles 
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to magnetite by compelling the magnetite to adopt an opposite charge. 
The pH for the bench top scale CoMag™ process was optimized 
using MS2 as the challenge virus. Several experiments were conducted with 
the pH ranging from 3.0 to 8.0 and the optimum pH at which the LRV for 
magnetite was the highest was determined to be pH 6.0 +\- 0.1 
CoMag™ Bench Scale 
CoMag™ is a magnetically enhanced technique for the removal of 
contaminants from wastewater. The CoMag™ process begins by passing 
influent wastewater through a pre-conditioning magnetic matrix, in order to 
create a locally induced magnetic moment or force, which is sensed by 
colloidal particles. The electrostatic charge present on each particle that 
passes through the pre-conditioning filter prevents aggregation of the 
colloids. Also, the thermal motion of each particle offsets its gravitational 
potential energy, resulting in random collisions. The target pH range of the 
pilot plant was broader (5.5 to 6.1) than the target pH range at the bench 
scale (6.0 +/- 0.1) because of factors, such as heavy metals and salts, which 
influence the pH of the wastewater flowing through the pilot plant. Because 
the bench scale model used a single sample of secondary effluent and the 
volume was constant, the pH was easily manipulated and the pH range 
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could be narrower. 
Bench scale experiments provide valuable information in a 
controlled environment regarding the inactivation and removal of viruses. 
There are limitations to bench scale experiments however, because the 
seeded virus may not truly represent the conditions of those occurring 
naturally in wastewater. For instance, viruses naturally present in sewage 
may be encapsulated in cell debris, aggregated, or adhered to solid 
particles. This, in turn, may prevent the virus from adhering to flocculants 
or coagulants. 
The physical removal of a virus from wastewater is determined by its 
surface structure and isoelectric point, the pH of the wastewater, and the 
degree of aggregation. The behavior of flocculants, coagulants, and 
magnetite toward viral particles depends on the composition, surface 
chemistry, and isoelectric point of the particles. In addition, the pH and 
composition of the wastewater are also important factors in the 
adsorption of viruses. 
The ideal matrix for this study would be one without variability and 
inhibitory substances such as reverse osmosis water. However, since the 
ultimate goal of this study was to evaluate a wastewater treatment 
process for the removal of viruses, it was necessary to choose wastewater 
as the matrix for the bench scale studies. Although the variability of 
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wastewater cannot be completely eliminated, the differences in virus 
removal were attributed to variability of viral response to the CoMag™ 
process as opposed to variability in the content of the wastewater for 
these particular bench scale studies. The inconsistent characteristics of 
wastewater, such as biochemical oxygen demand and total suspended 
solids, were minimized by using one batch of secondary effluent for all 
bench scale experiments. The minimization of this variability was more 
important than the limitations resulting from the use of a single grab 
sample of wastewater for all experiments. 
MS2 
MS2 coliphage is non-pathogenic to humans and is commonly 
found in environments where fecal contamination is present. MS2 is 
frequently used as a model or surrogate to evaluate the removal of 
enteric viruses because it closely resembles them in size, structure, and 
survival rate in the environment. 
The removal of MS2 from secondary effluent wastewater was 
evaluated, using a bench scale model of the CoMag™ process, without 
added magnetite and at room temperature (24°C). The average LRV for 
the removal of MS2, using the CoMag™ process, with the addition of 
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magnetite, was 1.1598 logs higher then the removal of MS2 without 
magnetite. The statistical analysis displayed in Table 1 and Table 2 
demonstrate a p value of 0.005, indicating that there is a significant 
difference in the removal of MS2, when magnetite is added, versus when 
magnetite is not added. Regarding the data, it can be concluded that 
the addition of magnetite has an enhanced effect on the removal of 
MS2. 
The robustness of the MS2 removal was also evaluated. This 
was achieved by determining that the mean LRV did not significantly 
differ for three trials performed on three different days. As presented in 
Figure 8, the average LRV for the removal of MS2 was 3.0495 for trial 1, 
2.9640 for trial 2, and 2.9525 for trial 3. A one-way unstacked ANOVA 
resulted in a p value of 0.890, indicating that there is not a significant 
difference, when comparing the removal of MS2 in each trial. The 
removal and enumeration of MS2 is therefore considered robust. 
To determine if temperature had a significant effect on the removal 
of MS2 two temperatures were examined: 4°C and 24°C. This 
temperature range reflects the anticipated conditions at the Concord, 
MA plant. For each of the experiments, MS2 and one of the three enteric 
viruses (poliovirus type 1, rotavirus strain Wa and adenovirus type 2) were 
spiked simultaneously into the wastewater and evaluated. The paired 
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comparisons were advantageous because they minimized variability, 
which would have affected the comparison of the viral removals. 
Statistical analysis resulted in a p value of 0.270, indicating that there is no 
significant difference in the removal of MS2, when in the presence of 
poliovirus, rotavirus, or adenovirus at 24°C. These results are shown in 
Tables 5 and 6. At 4°C, statistical analysis resulted in a p value of 0.476, 
indicating that there is not a significant difference in the removal of MS2, 
when in the presence of poliovirus, rotavirus, or adenovirus at 4°C. The 
results are shown in Tables 7 and 8. 
Statistical analyses, as displayed in Figures 9 and 10, illustrate that 
the removal of MS2 does not vary significantly, at 24° versus 4°C, when in 
the presence of another virus. The adsorption of MS2 appears to be a 
physical process which is independent of temperature and presence of 
poliovirus type 1, rotavirus strain Wa and adenovirus type 2 under the 
conditions tested for this research. 
The removal of MS2 from the secondary effluent samples, using the 
bench scale process, was significantly higher than the removal of poliovirus 
type 1, rotavirus strain Wa, and adenovirus type 2. These results are displayed 
in Figures 15 through 20. This conclusion can be attributed to the differing 
isoelectric points of the four viruses. The isoelectric points of poliovirus type 1, 
rotavirus strain Wa and adenovirus type 2 are higher than the isoelectric point 
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of MS2 which is 3.9 (Dowd et al., 1997). MS2 is more strongly electronegative 
in the pH range of the bench scale CoMag™ process (pH 6.0 +/- 0.1) 
therefore its attachment to the positively charged magnetite is higher 
than the attachment of the other three viruses. 
Poliovirus type 1 
Poliovirus, the most widely studied of all human pathogenic viruses, 
was prevalent in water and wastewater. Summarized in Tables 17 and 18, 
at 24°C, the LRV of MS2 was 0.6239 logs lower than poliovirus type 1. At 
4°C, the LRV of MS2 was 0.2555 logs lower than poliovirus type 1. The data 
are displayed in Tables 19 and 20. The LRVs of poliovirus and MS2, at 24°C 
and 4°C, were statistically significant. The LRV of poliovirus was 
significantly higher, at both temperatures, when compared to the LRV of 
MS2. This can possibly be attributed to the protein coat of poliovirus, 
which consists of 16 proteins, of which 25% alter their charge at a pH less 
then 7.0. Specifically, cysteine becomes negatively charged (SH —• S-), 
histadine becomes neutral (N+ —>N), and arginine and lysine become less 
positive (NH3+ —»• Nhb). Previous studies indicate that transformation of 
charge is imperative in the depletion of repulsive electrostatic forces, 
which may increase aggregation (Pearson et al., 1964). Since the 
114 
removal of poliovirus type 1 is higher than MS2 at both temperatures, MS2 
is a good indicator of the removal of poliovirus using the CoMag ™ 
process at the bench. 
When the removals of poliovirus type 1 at 24° and 4°C were 
statistically analyzed, the p value was 0.026. This low p value (<0.05) 
indicated that there was a statically significant difference in the removal 
of poliovirus, at the two different temperatures. The reduction in the LRV, 
at 4°C, as compared to 24°C, may be attributed to a decreased rate of 
Brownian motion, which is directly proportional to temperature. 
Rotavirus strain Wa 
At 24°C, the LRV of rotavirus strain Wa was 0.5726 logs higher than 
the removal of MS2. At 4°C, the LRV of rotavirus strain Wa was 0.6272 logs 
higher then the removal of MS2. Statistical analysis indicates that there is 
a significant difference in the LRV of MS2, at 24°C and 4°C, when 
compared to the LRV of rotavirus. Because rotavirus strain Wa is removed 
at a greater level than MS2 at the bench, MS2 would be an adequate 
surrogate for the removal of rotavirus strain Wa using the bench scale 
model of the CoMag™ process. 
There was no statistically significant difference in the LRV of rotavirus 
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at the two different temperatures, therefore the adsorption and removal 
of rotavirus is probably not dependant on temperature. Wastewater 
contains many organic compounds and interaction of the particles within 
a wastewater matrix is vastly complex. High concentrations of flocculants 
and coagulants are added to wastewater during the CoMag™ process to 
bind the organic compounds which compete with viruses for attachment 
to magnetite. The flocculants and coagulants also increase the positive 
charge on magnetite and viral adsorption is enhanced. The isoelectric 
point of rotavirus strain Wa is lower than the isoelectric point of poliovirus type 
1. Therefore rotavirus strain Wa is more strongly electronegative in the pH 
range of the bench scale CoMag™ process than poliovirus. The 
attachment of rotavirus strain Wa to the positively charged magnetite by 
attractive van der Waals forces may be stronger than the attachment of 
poliovirus type 1 making the temperature of the matrix insignificant. The 
data are summarized in Tables 21 through 24. 
Adenovirus type 2 
Adenoviruses are of medium size (90-100 nm), and are the largest 
non-enveloped virus. The virion contains a penton fiber^ or spike, that aids 
in attachment to the host cell. At 24°C, the LRV of MS2 was 0.6597 logs 
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lower then the removal of adenovirus type 2. At 4°C, the LRV of MS2 was 
0.5756 logs lower then adenovirus type 2. Statistical analysis indicates that 
there is a significant difference in the LRV of MS2 when compared to the 
LRV of adenovirus, at 24°C and 4°C. Adenovirus type 2 is removed at a 
greater level then MS2 at the bench under the test conditions employed 
for this research. Therefore, MS2 would likely be a sufficient surrogate for 
the removal of adenovirus type 2 using the bench scale model of the 
CoMag™ process. Statistical analysis also demonstrated that there is no 
difference in the removal of adenovirus type 2 at 24°C and 4°C. The 
adsorption and removal of adenovirus type 2 does not appear to be 
temperature dependent. Poliovirus type 1 has an isoelectric point that is 
much higher than adenovirus type 2. This may result in a stronger 
electronegative force than poliovirus type 1 in the pH range of the bench 
scale CoMag™ process. Like rotavirus strain Wa, the attachment of 
adenovirus type 2 to the positively charged magnetite by attractive van 
der Waals forces may be stronger than the attachment of poliovirus type 
1 making the temperature of the matrix insignificant. The data are 
summarized in Tables 25 through 28. 
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CoMqg™ Pilot Plant 
Human enteric viruses cannot be added to wastewater that is 
released into the environment because of the high expense of viral 
propagation and their pathogenicity to humans. The titers achieved from 
the propagation of most enteric viruses are too low for practical use in a 
100 gpm pilot plant. Therefore, a virus which is inexpensive to propagate 
and is non-pathogenic to humans was used as a model or surrogate. In 
previous viral removal studies, MS2 has been utilized as a surrogate for 
poliovirus, rotavirus and adenovirus. MS2 has similar morphological 
features, susceptibility to disinfection and survivability in the environment 
as compared to some enteric viruses. 
The average LRV for the removal of MS2 at 24°C, using the bench 
scale model, was 0.8163 logs higher than the pilot plant. Statistical 
analysis demonstrated a significant difference exists in the removal of MS2, 
using the bench scale model versus the pilot plant. The data is 
summarized in Tables 31 and 32. The removal of MS2 using the bench 
scale model is not an adequate representation of the removal of MS2 at 
the pilot plant because the bench scale model yielded a significantly 
higher LRV. 
The data for the CoMag™ pilot plant resulted in no statistically 
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significant difference in the removal of MS2, between trails. This result 
suggests that the removal of MS2 at the pilot plant for the time period 
tested is robust because the variability in the pilot plant stream does not 
have a significant effect on the removal of MS2. 
The significant difference between the LRVs of MS2 at the CoMag™ 
pilot plant scale verses the bench scale model can probably be attributed to 
the different target pH ranges for each scale. The target pH for the pilot 
scale CoMag™ process was 5.5 to 6.1 and the target pH for the bench scale 
was narrower at 6.0 +/- 0.1. Since the isoelectric point of MS2 is 3.9, its viral 
surface is more electopositively charged at a pH of 6.0, which was the 
targeted pH for the bench scale model. Therefore a higher LRV would be 
expected when testing at the bench. 
Another factor which may have contributed to the difference of the 
LRVs determined for the bench scale model verses the pilot plant process is 
the sampling method. At the bench, a single sample was pulled from each 
beaker and immediately assayed. Alternatively, sampling for the pilot scale 
plant was performed continuously. More specifically, a sample was pulled 
every 10 minutes over a period of three hours and assayed after a minimum 
hold time of 12 hours. The CoMag™ process removes particles, including 
viruses, through adsorption and aggregation. Since the adsorption of 
viruses to magnetite is reversible, extended transport and holding times for 
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the samples could result in separation of the virus particles. A 
consequence of this would be an increased viral titer resulting in a lower 
LRV. 
Although evidence supports that MS2 may be a good indicator of 
viral removal, these data suggest that it does not serve as an adequate 
surrogate for poliovirus type 1, rotavirus strain Wa and adenovirus type 2 
when using the CoMag™ process. The removal differences could be 
possibly due to inherent variability in sewage samples. Several factors 
potentially influenced the reduced LRV of MS2 at the pilot plant including 
the physiological state of the microorganism, the degree of aggregation, 
and the wastewater quality. 
More specifically, the reduced removal of MS2 at the pilot plant 
may have been due to inadequate mixing throughout the pilot plant 
process. In the bench scale model, the total working volume of 
secondary effluent was relatively small, 1000 mL, and mixing was highly 
controlled. At the pilot plant, the tanks had the capacity to mix 
thousands of gallons of water. The presence of dead zones in the tank, 
areas where MS2 did not come into contact with the added chemicals, 
may have contributed to the reduced LRV. Furthermore, the spiked MS2 
may have become encapsulated in cell debris, aggregated, or adhered 
to solid particles, which would have rendered it incapable of adhering to 
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the added magnetite, flocculent or coagulant. The physical properties 
such as total suspended solids and turbidity were not assessed in the 
secondary effluent used for the bench scale or pilot plant studies. 
Therefore, the solids content may have contributed to the variation in the 
removal of MS2. This is supported by the fact that the removal of MS2 
differed at the bench scale verses the pilot scale process. 
In addition, some of the difference in the LRVs of the viruses may be 
attributed to the enumeration assays, which were specific for each virus. 
MS2 utilizes a bacterial host while poliovirus types 1, rotavirus strain Wa and 
adenovirus type 2 require a continuous mammalian cell line. Continuous 
cell lines are more fastidious than bacteria and their growth media is 
complex and differs for each cell line used for these experiments. They 
are also more susceptible to cations, which are present in the CoMag™ 
processes. Cations may competitively adhere to the mammalian cells 
used to enumerate each virus. This would decrease the amount of virus 
able to infect the cell monolayer resulting in an artificially low viral titer. 
Viral aggregation may also result in an erroneously low viral titer. 
Future Experiments 
Several municipal and industrial wastewater treatment facilities are 
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advancing from utilizing exclusively primary and biological treatment, to 
tertiary treatment, to achieve higher contaminant removal levels now 
required by more recent environmental regulations (USEPA, 2006)(USEPA, 
2007). The CoMag™ process may be an effective tertiary treatment 
process, acting as a method to achieve the more stringent wastewater 
discharge permits. Past research indicates that the CoMag™ process is 
capable of reducing phosphorus levels to 0.01 mg/L, arsenic by 93%, total 
suspended solids by 98.6%, and biochemical oxygen demand by 63%, in 
secondary effluent (Cambridge Water Technology, 2007). Due to the 
ability of the CoMag™ process to achieve high levels of particulate 
removal and a > 2 LRV of MS2, as determined from the research 
presented here, it has the potential to greatly improve wastewater and 
drinking water treatment. Use of the CoMag™ process is beneficial 
because it is inexpensive, time efficient, and has a compact footprint. 
Additionally, less waste product is produced because the bound 
magnetite creates a compact sludge and the magnetite that is not 
bound is recycled reducing the high cost of sludge disposal. 
Despite these advantages, testing the CoMag™ process in the field 
would be challenging for several reasons. Firstly, the large volume of water 
commonly treated in a wastewater plant would make it difficult to collect 
a homogenous sample. Secondly, viruses that are pathogenic to humans 
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can not be seeded in a functioning wastewater plant because of the risk 
of infecting the public when discharged into the environment. 
Furthermore, many environmental factors could not be controlled for such 
as heavy metals, water flow (GPM), and temperature. 
In both the bench scale and pilot plant studies several variables 
were controlled for such as the volume of flocculant, coagulant, and 
magnetite, the pH and the settling time in order to minimize variation due 
to environmental factors. In addition, all bench scale experiments were 
conducted with a single sample of secondary effluent wastewater. To 
assess the impact of these variables on the resultant LRVs, future research 
should include bench scale studies conducted with wastewater samples 
collected from several different days and composite samples (where a 
sample is gathered every hour for 24 hours and combined). Furthermore, 
samples of dilute wastewater, such as when rain events occur, or 
concentrated wastewater, as during drought events, should also be 
assessed. 
Infectious enteric viruses are isolated from raw sewage and 
wastewater effluent in greater numbers during the winter months (Fong 
and Lipp, 2005). Furthermore, the efficiency of wastewater treatment 
plants decreases during the winter months (Olsen et al., 2005). This creates 
an increased potential for the release of enteric viruses into the 
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environment. Further research of the CoMag™ process may include 
evaluating seasonal effects on MS2 removal. This may provide an 
indication that the CoMag™ process could successfully reduce the 
quantity of enteric viruses released into the environment during the winter 
months. 
A further application of the CoMag™ process could include use as 
pretreatment for disinfection methods such as chlorination and ozonation, 
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BUFFERS AND REAGENTS 
1% Magnesium Chloride Solution 
Dissolve 1 g of MgCl2'6H20 (Fisher) into 99 mLs of distilled water. 
IQOx Streptomycin Sulfate/ Ampicillin Antibiotic Solution 
Add 0.15 g of both antibiotics (Sigma) to 100 mLs of distilled water. 
1x Phosphate Buffered Saline Solution (PBS) 
Dissolve 9.785 g of phosphate buffered saline powder (Sigma) into 1 L of 
distilled water. pH to 7.0 and autoclave at 121°C, 15 psi for 15 minutes. 
Store at room temperature. 
0.1% Crystal Violet Stain 
Dissolve 0.1 g Crystal violet into 99 mLs of distilled water. 
5M Hydrochloric Acid 
Add 56.9 mLs distilled water into a volumetric flask and bring up to 100 mLs 
with HCL. Store at room temperature. 
2M Sodium Hydroxide Solution 
Dissolve 80 g NaOH pellets (Fisher) with 1 L of distilled water in a plastic 
container. Store at room temperature. 
10% Formalin Fixative in Normal Saline 
Dissolve 8.5 g NaCI (Sigma) into 900 mLs distilled water, add 100 mLs of a 
37% Fomaldehyde solution. Store at room temperature. 
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Trypsin Solution 
Add 0.1 g of trypsin (Gibco) to 10 mL of distilled water. Filter sterilize 




IX Agar Overlay for MS2 Plaque Assay 
Dissolve 15 g powdered T-soy broth, 2.5 g NaCI, 5 g Yeast extract, 0.075 g 
CaCl2-2H20 and 7.5 g Bacto agar in 1 L distilled water. Boil to dissolve while 
mixing then dispense 5 mL portions into test tubes using a Cornwall syringe. 
Cap and autoclave test tubes at 121°C, 15 psi for 15 minutes. Store at 
room temperature, and melt when needed by autoclaving at 121°C, 15 
psi for 5 minutes. 
Cell Culture Media for the Propagation of BGMK. MA-104 and Caco-2 
Cells 
4.7 g Eagles MEM (Sigma) 
7.4 g Leibowitz L-15 (Sigma) 
4.24 g HEPES (Fisher) 
0.292 g L-glutamine (Sigma) 
0.75 g Sodium bicarbonate (Sigma) 
10 mL Nonessential amino acids (Gibco) 
Dissolve components in 1 L distilled water, pH solution to 7.2-7.4, filter 
sterilize, refrigerate until use. 
10% MEM for MA-104 and Caco-2 Cells 
5 mL Antibiotic/Antimycotic (Gibco) 
45 mL Fetal Bovine Serum (JRH Biosciences) 
450 mL of prepared cell culture media 
5% MEM for BGMK Cells 
5 mL Antibiotic/Antimycotic (Gibco) 
22.5 mLs Fetal Bovine Serum (JRH Biosciences) 
450 mL of prepared cell culture media 
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2% MEM Maintence Media for BGMK. MA-104 and Caco-2 Cells 
5 mL Antibiotic/Antimycotic (Gibco) 
9 mL Fetal Bovine Serum (JRH Biosciences) 
450 mL of prepared cell culture media 
2XMEM 
4.7 g Eagles MEM (Sigma) 
7.4 g Leibowitz L-15 (Sigma) 
4.24 g HEPES (Fisher) 
0.292 g L-glutamine (Sigma) 
0.75 g Sodium bicarbonate (Sigma) 
10 mL Nonessential amino acids (Gibco) 
5 mL Antibiotic/Antimycotic (Gibco) 
1 mL Kanamycin (Gibco) 
Dissolve components in 500 mL distilled water, pH solution to 7.2-7.4, filter 
sterilize, refrigerate until use. 
Medium 199 
2.437 g Ml99 (Sigma) 
0.075 g L-glutamine 
1.325 g Hepes 
0.175 g Sodium Bicarbonate 
0.025 g Magnesium Chloride 
Dissolve components in 115 mL distilled water, filter sterilize 0.22 Dm, 
refrigerate until use. 
Ml 99 Overlay 
79 mL Ml99 (Sigma) 
3 mL Neutral Red (Sigma) 
3 mL Antibiotic/Antimycotic (Gibco) 
Place in 37°C water bath. 
Trvptic Sov Broth for E. coli HS (pFamp)R Propagation 
Dissolve 30 g powdered T-soy broth into 1 L distilled water, stir and heat 
until dissolved. Add 5 mL/1 L of 1% MgCl2-6H20 solution, and autoclave at 
121°C, 15 psi for 15 minutes. After cooling add 10 mL/1 L of lOOx 
Streptomycin/Ampicillin solution. Refrigerate till use at 4°C. 
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